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Mycobacterium tuberculosis (Mtb) infections claim millions of lives per annum and the rise of 
drug resistance is expected to increase this disease burden particularly in Africa. Several 
pathogenic targets are consequently being assessed for drug development including the Mtb 
antioxidant defense network. This conserved network relies on thiol-based moiety couple 
systems to detoxify harmful reactive oxygen and nitrogen species elicited by the host immune 
response and both active and latent Mtb appear to be sensitive to redox protein targeting drugs. 
Curiously, despite the hypoxic granuloma microenvironment, Mtb is proficient in reducing 
hydrogen peroxide and oxygen radicals generated by host lymphocytes. To systematically 
uncover the structural properties of this network, the moiety couples within the network were 
simplified to moiety sums and compared to the antioxidant networks of E. coli and baker’s 
yeast using motif detection analysis. Our results show that Mtb has a unique bi-fan motif within 
the Mtb thioredoxin/peroxiredoxin system in which two peroxiredoxins, thiol peroxidase (Tpx) 
and the bacterioferritin comigratory protein (BCP), are reduced by both thioredoxin B and C 
respectively. Characterization of the bi-fan motif using mathematical and computational 
modelling revealed a greater tolerance to hydrogen peroxide and robustness to changes in 
thioredoxin B or C concentrations when compared to a bi-parallel motif suggesting that the 
bi-fan motif could play a critical role in Mtb persistence in vivo. Mtb BCP has not previously 
been kinetically characterized and along with thioredoxin reductase and thioredoxin C were 
synthesized on pET28a vectors for in vitro analysis. Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) expression of the clones in E. coli BL21 and nickel affinity chromatography (Ni-NTA) 
purification of the His-tagged proteins yielded pure protein samples. Thioredoxin reductase 
and thioredoxin C were assayed to determine their specific activities while BCPs’ kinetics 
regarding hydrogen peroxide reduction will be tested using a HRP competition assay in future 
studies. Overall, novel insights into the M. tuberculosis redox defence network were obtained 
through a combination of systems biology techniques and this work serves as a good starting 
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Chapter 1: Literature Review 
1. Introduction 
1.1. Mycobacterium tuberculosis, the single celled tank of the infectious disease world 
Tuberculosis (TB) is caused by a slow growing gram-positive bacterium known as 
Mycobacterium tuberculosis (Mtb) which belongs to the class Actinomycetes (Smith, 2003). 
To a lesser extent, the disease can also be caused by other members of the “Mycobacterium 
complex” namely M. africanum, M. bovis, M. canetti and M. microti (Asif, 2013). TB was 
described by Hippocrates in 400  B.C. where it was identified as “consumption”, “wasting 
away”, “kings evil”, “lupus vulgaris”, “the white plague” or “phthisis” (Ducati et al., 2006). 
Remnants of TB infections were found in Egyptian mummies from 2000 B.C. and a rare 
manifestation of TB, known as Pott’s disease or Gibbous deformity, was revealed amongst 
several of these mummies which developed into serious spine deformities and subsequent limb 
paralysis (Ducati et al., 2006). During the European Middle Age TB also manifested itself as 
Scrofula, a rare form of TB that affects the lymph nodes. The infection was particularly found 
around the neck and shoulder region and was believed that the cure came from the power of 
the divine touch of kings. By the beginning of the 20th century, TB had claimed many renowned 
lives including Charlotte Brontë (and most of the Brontë family), John Keats, Lord Byron, 
George Orwell, Castro Alves and Eleanor Roosevelt among many others (Ducati et al., 2006).  
The origin of M. tuberculosis, along with other disease causing Actinomycetes species 
like M. leprae (Ducati et al., 2006), has been the subject of intense investigation. It is believed 
that the genus Mycobacterium was initially found in soil and that some species evolved to 
survive within mammals. The fact that TB was so vastly spread throughout the globe roughly 
4000 years ago suggested that there was a common vector for transmission (Ducati et al., 2006). 
The domestication of cattle roughly 10,000 to 25,000 years ago (Smith, 2003) would have 
allowed the passage of the pathogen from livestock to humans via unpasteurized milk and 
untreated meat products (Ducati et al., 2006). M. bovis, the mycobacterium that causes a 
TB-like disease in cattle, was initially believed to be the evolutionary precursor to 
M. tuberculosis that developed mechanisms of survival within the human host. However, 
phylogenetic studies disproved this hypothesis and concluded that the two mycobacteria 
co-evolved from a common precursor, possibly M. canetti, which shows an older genome but 





The most common clinical manifestations of pulmonary TB include chronic coughing, 
sputum production, loss of appetite, weight loss, fever leading to night sweats and haemoptysis 
(the coughing up of blood). Extrapulmonary TB occurs when other organs of the body become 
infected and is present in 10 to 42% of patients. The development of extrapulmonary TB 
depends on multiple factors, some of which include ethnic background, age, presence or 
absence of an underlying disease, immune status and the strain and genotype of Mtb causing 
infection (Zumla et al., 2013). Coinfection with the human immunodeficiency virus (HIV) 
further complicates management and treatment of TB infection. Once infected with HIV, the 
patient soon after develops active TB which mimics the early stages of HIV-negative 
individuals whom are immunocompromised (Zumla et al., 2013).      
Tuberculosis is transmitted via aerosolized droplets containing the infectious 
M. tuberculosis bacterial cells which are then inhaled by an uninfected individual where the 
infection resides before the cycle can continue once more (Smith, 2003). The bacilli, like the 
majority of Mycobacteria, are relatively resistant to drying, alkali and many other chemical 
disinfectants, making it very difficult to control transmission in urban environments (Ducati et 
al., 2006). The inability to control this infectious agent has now led to TB being a global threat, 
infecting one-third of the world’s population and claiming approximately 2 million deaths per 
annum (Karakousis et al., 2004).  
The highest TB burden is found in Asia and Africa (Figure 1.1) with India and China 
collectively accounting for almost 40% of the total world’s TB cases. African regions have 
24% of the world’s total reported cases and the highest rates of death per capita (World Health 
Organization, 2012). Along with drug-susceptible Mtb strains, multidrug-resistant (MDR-TB) 
(Gomes et al., 2014) and extensively drug-resistant (XDR-TB) strains (Asif, 2013) have 
developed with India, China, the Russian Federation and South Africa collectively making up 






Figure 1.1. Estimates of the TB and HIV prevalence per 100 000 individuals in 2014. The 
increase in the shade of green denotes a higher estimate in reports for new TB cases around the 
globe while the increase in the shade of brown denotes a higher HIV prevalence percentage 
amongst all age groups (World Health Organization, 2015). (Permission to reproduce this figure 
was granted by the World Health Organization Press). 
Resistance to the antibiotics isoniazid (INH) and rifampin (RMP), with or without 
resistance to other first line anti-TB drugs such as pyrazinamide, ethambutol and streptomycin 
(Gomes et al., 2014) has become the definition of MDR-TB (Campos et al., 2003). XDR-TB 
refers to strains resistant in vivo to at least isoniazid and rifampicin (MDR-TB definition) as 
well as to three or more of the six main classes of second line anti-TB drugs namely 
aminoglycosides, polypeptides, fluoroquinolones, thioamides, cycloserine and 
p-aminosalicyclic acid. Treatment of patients with MDR- and XDR-TB is significantly more 
complex, less effective, more toxic and more expensive than that of treatments available against 
drug-susceptible strains (Gomes et al., 2014). From a clinical perspective, MDR-TB is 
associated with inadequate treatment regimens, failure to adhere to the treatment for the 
specified time period, poorly managed TB-control programs and inconsistent hospital infection 





MDR-TB infections are still manageable with use of second line anti-TB drugs. However, most 
treatments against XDR-TB are ineffective consequently making it one of the most challenging 
threats to public health worldwide (Fattorini et al., 2007). The costly and lengthy course of 
treatment leads to low patient compliance, especially in developing countries, which 
contributes significantly to the further rise and spread of drug-resistant strains. Clinical cure 
rates for individuals with MDR-TB in developing areas are less than 50% emphasising the lack 
of treatment options and adherence, along with the desperate need to find new treatment options 
(Harbut et al., 2015). 
In the South African context, TB along with HIV coinfection poses an enormous threat 
to the well-being of many individuals. It was recognized that the South African childhood TB 
burden is one of the largest proportions with regard to the worldwide total TB burden. 
Disturbingly, 20% of all these cases were estimated to be children of 5 years or younger (Zar 
et al., 2012). TB prevention can be achieved through various strategies, some of which include 
improvement of living conditions, immunization, better control and detection methods, use of 
isoniazid (INH) prophylaxis and highly active antiretroviral therapy (HAART) in HIV-infected 
individuals (Zar et al., 2012). However, South Africa suffers from the lack of substantial and 
adequate living conditions along with a lack of access to appropriate treatment (Grange and 
Zumla, 2008). A study conducted in Cape Town, South Africa, found that INH treatment alone 
reduced TB incidence and mortality in children by 72 and 54% respectively. A follow-up study 
placed children on a five year treatment plan with both INH and HAART and yielded promising 
results with a 90% reduction in TB incidence  (Zar et al., 2012). These results suggest that TB 
treatment alone could play a significant role in controlling the disease provided that patients 
adhere to the correct treatment regime.  
The South African Health Department as well as the World Health Organization (WHO) 
compile yearly reports for diseases known to be causing great impact and concern in South 
Africa and the world respectively. These agencies then implement strategies for disease control 
and set targets by which the disease should be managed and controlled. For example, the WHO 
aimed to cut total global cases of TB by at least half by 2015 in the STOP TB strategy and 
totally eradicate the disease from 2015 - 2035 in the END TB strategy (Table 1.1, World Health 
Organization, 2012 and World Health Organization, 2015). The WHO have successfully 
implemented their STOP TB strategy as both TB prevalence and mortality have decreased by 
roughly 50% from 1990 until 2015 (Table 1.1), this also indicates that the END TB strategy 





Health have also released data showing the number of cases of infected individuals (Figure 1.2) 
and the TB cure rate and TB mortality (Figure 1.3) with a general trend indicative of increasing 
TB infections despite strategies put in place to control spread of the disease. Fortunately the 
cure rate has also increased, revealing increased access to substantial health care and proper 
TB treatment regimes. Disappointingly, the mortality rate for TB remains constant at roughly 
7% (Figure 1.3). 
Table 1.1. Data from the WHO 2015 report highlighting decrease in global TB prevalence and 
mortality from 1990 until 2015 as well as the milestones and targets set by WHO with the 
initiation of the END TB strategy beginning in 2015 
Vision 
A world free of TB 
- zero deaths, disease and suffering due to TB 
Global TB reduction and successful regions reaching the target by 2015 since 1990 




Americas, South-East Asia, 




Americas, Eastern Mediterranean 




2020 2025 2030 End TB - 2035 
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Figure 1.2. The TB incidence rate (per 100 000 individuals) in South Africa from 2002 up until 
2011. This plot was constructed using data obtained from “Annual Performance Plan 
2012/2013-2014/2015”, Department of Health, South Africa. (2012) and “National Strategic 
Plan on HIV, STI’s and TB 2012 - 2016”, South African National AIDS Council. (2011).  
 
Figure 1.3. The South African TB cure rate % (Blue diamond) and TB mortality rate percentage 
(Red square). This plot was created using data obtained from "National Strategic Plan on HIV, 
STI's and TB 2012 - 2016", South African National AIDS Council. (2011). 
1.2. Ineffective preventative measures against tuberculosis and its ability to evade 
eradication 
The risk of developing an active TB infection is significantly increased by co-infection 
with the acquired immunodeficiency syndrome (AIDS) and other immune-compromising 

































































Mtb infected individuals. The only recognized vaccine against tuberculosis, the M. bovis 
Bacillus Calmette-Guérin (BCG) vaccine has proved to be inadequate against emerging 
outbreaks of tuberculosis, particularly in adults (Korbel et al., 2008). The BCG vaccine, 
although ineffective for adults, is regularly administered to children at birth (Ducati et al., 2006) 
to protect against severe forms of TB such as TB meningitis and miliary TB (World Health 
Organization, 2012). When controlled clinical trials where conducted, the BCG vaccine only 
had an estimated overall efficacy of approximately 50% for the prevention of TB in 
children (Zumla et al., 2013). Yet another drawback to use of the vaccine is that it is not 
recommended for use in infants known to be infected with HIV (World Health Organization, 
2012). Thus there is a need to develop a better BCG vaccine or create new vaccines entirely, 
to combat TB in both children and adults. The World Health Organization has described two 
approaches in achieving these goals. First, develop vaccines that will outperform the ‘old’ BCG 
vaccine such as an improved version or a new attenuated live M. tuberculosis vaccine. The 
second approach is to develop a “prime boost” strategy in which BCG continues to be given to 
infants and at a later stage (young adult) a new dose of the BCG vaccine is administered once 
again to help aid in immunity against development of active TB (World Health Organization, 
2012). An updated report from WHO shows that various vaccines are now in phase two and 
three of clinical trials. These new vaccines namely M72/AS01E, H1:IC31, H4:IC31, H56:IC31, 
VPM 1002, RUTI, MTBVAC and M. Vaccae, are augmentations of the original BCG vaccine 
aimed at preventing MDR-TB and XDR-TB (World Health Organization, 2015).  
Central to the vaccine challenges described above is that Mtb cells have evolved genetic 
and physiological mechanisms to remain viable within the hostile microenvironment of the 
host lung tissue. These mechanisms include redox defence gene/protein networks, a relatively 
impermeable cell wall structure and the secretion of certain proteins to the extracellular 
environment. These factors work in conjunction with one another to aid in the survival and 
spread of Mtb within the activated macrophages of the host immune system (Sharma et al., 
2012).  
1.2.1. The M. tuberculosis cell wall structure and function 
An interesting feature of the Mycobacterium genus is their cell envelope which has a high 
lipid content and constitutes 40% of the cell’s dry weight. The Mtb cell wall consists of multiple 
lipoglycans such as lipoarabinomannan (LAM), lipomannan (LM) and 





of the cell wall and outer membrane of any given cell is to protect and enclose its intracellular 
constituents, but the Mtb cell envelope can also coordinate host-pathogen interactions which 
aid in the pathogens’ ability to  avoid suppression by the host immune system (Karakousis et 
al., 2004).  
LAM phosphatidylinositol-anchored lipoglycans are composed of a mannan core with 
oligoarabinosyl side-chains with diverse biological functions. LAM is the most prominent cell 
wall component, making up 5 mg.g-1 of the cell’s weight and can be broken down into three 
sub-types. The three sub-types, each having their own function in protecting the cell, are 
Man-LAM which is characterized by its extensive mannose capping, phospho-myo-inositol 
capped-LAM (PILAM) and Ara-LAM which lacks mannosylation in the arabinan termini 
(Karakousis et al., 2004). Another key structural component of the outer membrane of Mtb is 
mycolic acid, a high molecular weight α-alkyl β-hydroxy fatty acid tasked with maintaining 
the structural integrity of the cell wall and membrane and more specifically the cyclopropane 
rings aid in oxidative stress protection against compounds such as hydrogen peroxide 
(Figure 1.4 F) (Takayama et al., 2005).  
 
Figure 1.4. Cell wall components found in Mycobacterium tuberculosis include (A) plasma 
membrane, (B) peptidoglycans, (C) arabinogalactan, (D) mannose-capped lipoarabinomannan, 
(E) plasma membrane- and cell envelope-associated proteins, (F) mycolic acids and (G) 
glycolipid surface molecules associated with mycolic acids (Karakousis et al., 2004). 
(Permission to reproduce this figure was granted by RightsLink).  
This barrier protects against certain antitubercular drugs creating a first-line of defence 
which contributes to the overall virulence of Mtb (Zumla et al., 2013). With respect to directing 
macrophage function, mannose capping of LAM seemingly appears to direct the macrophage 





Ara-LAM is more effective in eliciting pro-inflammatory cytokine responses (Karakousis et 
al., 2004).  
1.2.2. Secreted Mtb proteins are partially responsible for the bacterium’s survival 
Mycobacterial survival also depends on protein export and Mtb cells have specialized 
secretory systems such as the Sec-dependent secretion pathway that transports N-terminal 
signal sequence containing proteins across the cytosolic membrane and the twin-arginine 
transporter (Tat) system that is capable of transporting folded molecules across the membrane 
(Pieters, 2008). Recent studies have shown that mycobacteria, including Mtb, use the ESX-1 
system to secrete the 6 kDa early secretory antigenic target (ESAT-6) and the 10 kDa culture 
filtrate protein (CFP-10) into the extracellular environment (Huppert et al., 2014). Both of these 
proteins, and possibly other compounds, are important T-cell antigenic targets and are therefore 
essential for the evasion from the host immune system. Apart from ESX-1, four other systems 
ESX-2 to ESX-5, are present with independent transport functions and it has been established 
that they are important for mycobacterial growth (Pieters, 2008). Interestingly, the 
mycobacterial KatG (catalase/peroxidase defence protein) and SodA (superoxide dismutase) 
enzymes are found in the culture filtrate of Mtb inferring their site of action can also be 
extracellular (Smith, 2003).    
1.3. Redox defence networks and the possibility of deciphering drug targets within 
In addition to the aforementioned membrane-dependent survival mechanisms, Mtb has 
also evolved multiple protein-dependent defensive systems to deal with the continuous 
oxidative stress experienced from the host immune defence and their microenvironment. 
During the course of infection, Mtb resides within the macrophages of the granuloma and the 
cells are constantly exposed to reactive nitrogen species (RNS), reactive oxygen species (ROS) 
and other toxins released by macrophages for impeding bacterial cell growth. Granuloma 
formation is a characteristic feature of TB infection and consists of macrophages and T-cells 
(CD4+ and CD8+) of the host immune system migrating to the site of infection to contain and 
control the Mtb infection (Tufariello et al., 2003). The granuloma serves as a barrier, protecting 
the surrounding tissue from the pathogen whilst simultaneously creating a hypoxic 
microenvironment to curb the growth of the Mtb cells contained within (Hatzios and Bertozzi, 
2011). ROS are ultimately generated from O2 which is abundant within the lung environment 
and is converted during the oxidative burst within the macrophage into the superoxide ion 
(O2





Nitric oxide (NO) and related RNS such as the peroxynitrite anion (OONO-) (Tufariello et al., 
2003) are also generated by the enzyme-inducible nitric oxide synthase (NOS2) of activated 
macrophages. It was found that toxic nitrogen oxides play a significant role in protection 
against human tuberculosis, with abundant NOS2 protein expression observed within 
functioning granulomas (Ohno et al., 2003). The main purpose of RNS and ROS are to damage 
Mtb DNA, lipids and proteins via oxidation reactions (Hemnani and Parihar, 1998; Kashmiri 
and Mankar, 2014). Mtb cells have nevertheless evolved various detoxification mechanisms to 
neutralize these reactive species and ensure their survival within the hypoxic granuloma 
environment. Some of these systems include the thioredoxin/thioredoxin reductase (Trx and 
TR respectively) system (Lu and Holmgren, 2014), the alkyl hydroperoxidase systems 
(AhpCDE) (Jaeger and Flohé, 2006), the bacterioferritin comigratory protein (BCP) system 
(Jeong et al., 2000), the catalase/peroxidase (KatG) system (Chouchane et al., 2000) and the 
low-molecular-weight thiol, mycothiol/mycoredoxin-1 (MSH and Mrx-1 respectively) 
network (Antelmann and Hamilton, 2012) which work in conjunction with one another to 
neutralize the constant threat from the human immune system to ensure Mtb survival.  
With the emergence and spread of antibiotic-resistant bacterial infections, there was an 
increased urgency to find new drugs with novel mechanisms of action. Recent studies have 
suggested that the activities of some drugs are mediated by the downstream redox effects on 
metabolic and homeostatic networks within bacteria (Harbut et al., 2015). A possible target 
pathway in Mtb is the thioredoxin (Trx/TR/NADPH) system which is linked to numerous 
cellular processes including DNA synthesis (Powis et al., 2000) and protecting the cell from 
ROS (Zhao et al., 2006). Auranofin, a FDA-approved antirheumatic drug, consists of a gold(I) 
center coordinated to a thiosugar and triethylphosphine  which inhibits the enzyme thioredoxin 
reductase (TR) by displacing two ligands from gold consequently forming a tight complex 
between the metal and active site cysteines of thioredoxin reductase (Marzano et al., 2007;  
Harbut et al., 2015). As dormant Mtb is able to reside within the host for decades (Kumar et 
al., 2011), auranofin’s efficacy against both active and more intriguingly dormant Mtb cells 
has drawn huge attention to the drug (Harbut et al., 2015). The repurposing of approved drugs 
provides a more rapid and cost effective route compared to clinical trials that test new drugs 
(Figure 1.5). Significantly this study also highlighted the vulnerability of the redoxin networks 






Figure 1.5. Therapeutic companies and academic institutions are investing less time and money 
into antibiotic research and development due to lack of funding and a significant return on 
development cost. A general decrease can be observed over the past four decades where fewer 
drugs are being developed to address the rise in drug resistant bacteria (Ventola, 2015). 
(Permission to reproduce this figure was granted by Elsevier Limited). 
 
Another drawback for conventional antimicrobial agents is the development of multiple 
drug resistances and the consequent need to administer higher doses of antibiotics which may 
result in host toxicity. Therefore, finding new ways of drug administration is also being 
explored to increase the efficacy of drug therapy. One such way of increasing the efficacy of 
drugs is the use of antimicrobial nanoparticles (NP’s) (Huh and Kwon, 2011). NP’s offer 
distinctive advantages in diminishing acute toxicity, overcoming resistance and lowering cost 
when compared to conventional antibiotics. Antimicrobial NP’s consists of metal and metal 
oxides, natural occurring antibacterial substances, and in conjunction with antibiotics have an 
increased antibacterial effect. Common metals used in NP’s are silver, copper, zinc oxide, 
titanium oxide, gold and the use of carbon nanotubes. Metals increase the antimicrobial effects 
of antibiotics by disrupting the lipid bilayer (gold and zinc oxide), attacking the respiratory 
chain and cell division machinery (silver) and the production of ROS (titanium oxide and 
copper) (Huh and Kwon, 2011). Metals are well known for forming inhibitory complexes with 
enzymes (Louie and Meade, 1999) which together with antibiotics could prove to be successful 





2. Threat of hydrogen peroxide on M. tuberculosis survival during infection 
Hydrogen peroxide is a major threat to pathogenic and non-pathogenic cells based on its 
ability to form highly reactive radicals and requires multiple systems working in conjunction 
to neutralize it when present at high concentrations. Hydrogen peroxide itself is generated in 
numerous biological processes, is involved in redox signalling (Netto and Antunes, 2016) and 
although it is a strong oxidant, hydrogen peroxide itself is relatively unreactive to most 
biological molecules and because of this can diffuse across larger distances than other ROS. 
The more favoured reactions with hydrogen peroxide involve metal centres, selenoproteins and 
thiol-based proteins (cysteine residues). Intracellular Fenton chemistry is one of the main 
processes involved in hydrogen peroxide reactive radical formation and involves the Fe2+ ion 
reacting with hydrogen peroxide to release Fe3+ and two OH˙ radicals. The OH˙ radicals can 
cause damage to DNA, lipids and proteins within the cells eventually resulting in cell death 
(Winterbourn, 2013).  
3. Redoxin defence networks in M. tuberculosis cells 
The thiol-based redox defence mechanisms in Mtb cells are based on the thiol oxidation 
chemistry of cysteine (Cys). Sulfur occurs in major classes of biomolecules such as amino acids 
(methionine, cysteine, taurine, homocysteine and selenocysteine) and its reactivity is derived 
from its innate chemistry. In cysteine residues, sulfur is fully reduced with an oxidation state 
of -2 and its low redox potential (Eo = -0.27 to -0.125 V) allows the thiol side chain to undergo 
a range of oxidative modifications (Gupta and Carroll, 2014; Nauser et al., 2015). Interestingly, 
the fractional cysteine content of different species’ proteins increases with an increase in 
apparent species complexity (Miseta and Csutora, 2000; Gupta and Carroll, 2014). The increase 
in cysteine content with higher complexity organisms could reflect the various redox states that 
the thiol/sulfhydryl group undergoes leading to increased redox functionality (Poole, 2015). 
For example, during eukaryote signalling processes, oxidized peroxiredoxins transmit 
information about the environmental oxidative stress conditions by transferring oxidizing 
equivalents to thiol groups of regulatory proteins who themselves are understood to be less 
reactive with oxidants such as hydrogen peroxide (H2O2) (Winterbourn and Hampton, 2008; 
Winterbourn and Hampton, 2014).  
Reactive cysteines arranged into an active site -CXXC- motif are considered crucial in 
redox signal sensing and antioxidant defence. Those cysteine residues can either coordinate a 





exchange reactions (Botello-Morte and Fillat, 2014). Thiolate radicals of cysteine residues 
(R-S-) can participate in free radical chain reactions to form a range of oxidized species 
generated by two electron chemistry. These cysteine residue modifications allow a range of 
biomolecules, including low-molecular-weight thiols and oxidoreductases, to undergo 
reversible redox reactions to maintain a reduced environment within the cellular cytoplasm and 
help protect the cellular components from oxidative damage.  
3.1 The low-molecular-weight thiol mycothiol (MSH) sustains a reduced intracellular 
environment 
The class of Actinobacteria is a very large and diverse group of gram-positive, high GC 
content bacteria with members of varying morphology found in an extensive range of habitats 
from soil to seawater and even on the skin, lungs and in the gastrointestinal tract of humans. 
They cause multiple diseases such as leprosy, tuberculosis and diphtheria but have also been 
utilized in bioremediation projects. Inhabiting a diverse range of habitats, Actinobacteria have 
to deal with a wide range of organic compounds and cellular redox threats and therefore utilize 
mycothiol (MSH, also known in literature as AcCys-GlcN-Ins), rather than glutathione, to 
maintain redox balance within the cell (Newton et al., 2006). 
Mycothiol is the major low-molecular-weight thiol present in Mtb, often present in 
millimolar amounts with analogous functions to the glutathione (GSH) system which is 
referred to as its cousin system (Newton et al., 2006). Promising work on mycothiol 
biosynthesis was conducted by Bornemann et al., 1997, who started working with synthetic 
GlcN-Ins to assay extracts of Mycobacterium smegmatis for enzyme activity. The work on 
mycothiol biosynthesis has since progressed with researchers now able to elucidate the entire 
biosynthesis pathway. Mycothiol biosynthesis is a multistep pathway and is carried out by what 
was originally thought to be only four proteins: MshA, MshB, MshC and MshD (Newton and 
Fahey, 2002). However, precursors utilized by MshA were not clear and it was later determined 
that another enzyme encoded by ino1 (myo-Inositol-1-phosphate synthase) was responsible for 
converting Glc-6-P into Ins-P (Newton et al., 2008). The Ins-P is converted to GlcNAc-Ins-P 
by MshA1 (MSH glycosyltransferase) by the addition of UDP-GlcNAc and the subsequent 
release of UDP. The phosphate is then removed by MshA2 (MSH phosphatase) releasing 
GlcNAc-Ins. MshB (MSH deacetylase) then removes the acetyl group releasing CH3COOH 
and GlcN-Ins. The GlcN-Ins is then acted upon by MshC (MSH ligase) which links a cysteine 





acetyltransferase) adds on an acetyl group from AcetylCoA creating AcCys-GlcN-Ins 
(mycothiol, MSH) and releasing coenzyme A (CoA).  
Mycothiol acts upon a range of alkylating compounds including formaldehyde and nitric 
oxide, by reacting and creating a mixed compound/disulfide (MSR, where R is the toxin). 
These mixed compounds/disulfides (MSR) are then cleaved by a mycothiol conjugate amidase, 
Mca, to release AcCysR (mercapturic acid, where R is the toxic compound) that is eventually 
transported out of the cell and GlcN-Ins which is recycled back into the mycothiol biosynthesis 
pathway (Newton and Fahey, 2002). Mycothiol is also involved in protein S-mycothionylation, 
a process in which mycothiol binds to cytosolic protein cysteine residues (R-SOH) protecting 
them from hyperoxidation, a process analogous to S-glutathionylation which is characteristic 
of the glutathione system (Figure 1.6) (Gallogly and Mieyal, 2007).  
 
Figure 1.6. Summary of the E. coli glutathione S-glutathionylation (A) and the Actinomycetes 
mycothiol S-mycothionylation processes (B). (A) Protein disulfides are reduced by 
thioredoxin A (TrxA) while S-glutathionylated proteins are reduced by glutaredoxins (Grx). 
TrxB represents thioredoxin reductase and oxidized Grx is reduced by GSH to give GSSG 
which is recycled back to GSH by glutathione reductase (Gor). (B) S-mycothionylated proteins 
are reduced by Mrx resulting in an active protein-SH and the Mrx-SSM intermediate. The 
Mrx-SSM intermediate is thereafter reduced by MSH, leading to MSSM formation which is 







(referred to in text) represents mycothione reductase and Mrx represents mycoredoxin in this 
figure. (Permission to use this figure was obtained from RightsLink).  
Reduced mycoredoxin-1 (Mrx-1) rescues the mycothionylated proteins by forming a 
mixed disulfide with the mycothiol molecule and releasing the active protein. The mixed 
disulfide between mycothiol and mycoredoxin-1 is thereafter cleaved by the addition of a 
second mycothiol molecule, creating mycothione (MSSM) and releasing the reduced form of 
mycoredoxin-1 (Figure 1.6 B). Mycothione is thereafter reduced, releasing two mycothiol 
residues at the expense of NADPH via mycothione reductase (MR) (Van Laer et al., 2012). 
3.2 Central hub of the Mtb redox defence: the thioredoxin (Trx) system 
The biologically active thioredoxin system comprising NADPH, thioredoxin (TrxB and 
TrxC) and thioredoxin reductase (TR) is a central disulfide reductase system (Figure 1.7) that 
provides electrons to a large range of proteins making it one of the major hubs for distributing 
reducing equivalents through the Mtb cell. For example, the thioredoxin system is critical for 
DNA synthesis by reducing ribonucleotide reductase and plays a critical role in defence against 
oxidative stress in the cell by extension of its disulfide bond reduction capabilities (Powis et 
al., 2000 and Zhao et al., 2006). Thioredoxin is a relatively small reductase protein of 12 kDa, 
contains a conserved -WCGPC- active site motif (Olson et al., 2013) and is ubiquitously 
present in archaea, bacteria and eukaryotes. It is made up of five β-strands (core of the protein) 
surrounded by four α-helices with the active site being found after the β2-sheet. Many other 
critical enzymes in thiol-dependent antioxidant systems such as glutaredoxin, peroxiredoxin 
and glutathione peroxidase also share the thioredoxin fold structure but differ in catalytic 
mechanisms (Lu and Holmgren, 2014).  
The genome of Mtb encodes three thioredoxins (TrxA, TrxB and TrxC encoded by trxA, 
trxB1 and trxC respectively) and bears a single copy of the thioredoxin reductase gene, (TrxR, 
encoded by trxB2). Of the three thioredoxins, TrxB and TrxC are involved in reduction of 
peroxides, dinitrobenzene and hydroperoxides in vitro. The central involvement of the 
thioredoxin system in antioxidant defence makes it an ideal drug target towards inhibiting one 
of the major redox hub systems in Mtb (Akif et al., 2008). However, TrxA of Mtb was found 








Figure 1.7. Electron flow from NADPH to thioredoxin (Trx) allows reduction of oxidized 
proteins (Protox) to the reduced protein state (Protred) by thiol/S-S exchange. The grey oval 
shows the thioredoxin reductase (TR) enzyme and the flavin adenine dinucleotide redox 
cofactor (FAD/FADH2) that allows electrons to pass to thioredoxin (Trx) shifting the balance 
between the oxidized (TrxSS) and reduced forms (TrxSH). (This figure was adapted from 
Collet and Messens, 2010).  
A knock-out mutant study conducted on the thioredoxin reductase (trxB2 gene) of Mtb 
shows that when the bacterium lacks sufficient amounts of thioredoxin reductase other cellular 
processes are also impeded. It was found that the thioredoxin reductase mutant displayed 
stunted growth when cultured in rich medium, failed to establish and maintain infection in mice 
models, was prone to lytic cell death, displayed increased cytoplasmic thiol oxidization levels 
and increased susceptibility to antimicrobial compounds except for auranofin, a 
gold-containing thioredoxin reductase inhibitor (Lin et al., 2016). The numerous detrimental 
effects outlined when inhibiting the thioredoxin system supports the claim that this system is 
the central reducing hub of the antioxidant defence systems within Mtb. Thioredoxins have two 
key responsibilities within the cell by acting as electron carriers to supply reducing equivalents 
to pathways involved in biosynthesis and to protect cytosolic proteins from inactivation or 
aggregation under oxidative conditions (Arnér and Holmgren, 2000b). Under hypoxic and 
oxidative conditions, such as those Mtb is exposed to in the granuloma microenvironment, the 
protection of cytosolic proteins from oxidative damage becomes particularly important (Van 





Thioredoxins’ role in the antioxidant response depends on a cascade of electrons from 
NADPH to thioredoxin reductase and from thioredoxin reductase to thioredoxin B and C 
(Figure 1.7) (Cumming et al., 2014). Thioredoxins B and C are both able to consequently pass 
the electrons from thioredoxin reductase onto other proteins including thiol peroxidase (Tpx) 
which completes the electron cascade by reducing oxidants such as hydrogen peroxide into 
water (Jaeger et al., 2004; Lu and Holmgren, 2014). The thioredoxin system is also active on a 
wide range of oxidizable protein molecules, capable of reducing alkyl hydroperoxidase 
sub-unit C (AhpC) (Lu and Holmgren, 2014), mycothiol disulfides (mycothione, MSSM) 
(Attarian et al., 2009) and the bacterioferritin comigratory protein (BCP) peroxiredoxin by 
either TrxB or TrxC (Comtois et al., 2003). Tpx, BCP and AhpE belong to a large family of 
proteins known as peroxiredoxins (Prx) which reduce oxidants and are recycled by thioredoxin 
and low-molecular-weight thiols of the cell. Interestingly, from a eukaryotic perspective 
peroxiredoxins are also known to coordinate cell stress response via their role in peroxide 
signalling (Perkins et al., 2015).  
3.3 Vastly abundant redox defence proteins of Mtb: the Mtb peroxiredoxins  
Peroxiredoxins are ubiquitously distributed through all living kingdoms and cellular 
compartments (Hugo et al., 2012) with peroxiredoxins constituting 0.1 – 0.8% of the total 
protein in mammalian cells, amongst the top ten most abundant proteins in E. coli and are the 
second or third most abundant in erythrocytes (Wood et al., 2003). The genome of Mtb encodes 
four different thiol-dependent peroxidases of the peroxiredoxin family: Tpx, AhpC, AhpE and 
BCP. In the presence of hydrogen peroxide, organic hydroperoxides, hypohalous acids (HOX), 
peroxynitrites and trace metals, the peroxidatic cysteine (Cp) of peroxiredoxins is oxidized to 
sulfenic acid (Cys-SOH) and in the case of prokaryotes, rapidly forms a disulfide bond (S-S) 
with the resolving cysteine (Cr) whereas eukaryotic disulfide bond formation is much slower 
(Figure 1.8) (Klomsiri et al., 2011). In large or excess concentrations of oxidizing agents, the 
Cys-SOH can be further oxidized to cysteine sulfinic (Cys-SO2H) and sulfonic (Cys-SO3H) 
acids in a process known as hyperoxidation which ultimately renders the antioxidant proteins 
inactive (Chung et al., 2013). In bacterial cells hyperoxidation is an irreversible process as they, 
unlike eukaryotic cells, lack the protein sulfiredoxin which can reverse the hyperoxidized 










Reduction of the disulfide bond between the peroxidatic and resolving cysteine residues, 
is mediated by thioredoxin or other related oxidoreductase proteins at the expense of NADPH 
or NADH, releasing both thiols on the peroxidatic and resolving cysteines in the reduced forms 
Cys-S- and Cys-SH respectively, to undergo the oxidative process once more (Gupta and 
Carroll, 2014). This simple reversible reaction is one of the central antioxidant mechanistic 
schemes present in Mtb, allowing various proteins to cycle through the oxidized and reduced 
states (Winyard et al., 2005).     
The peroxiredoxin family can be further categorized into three mechanistic classes, 
namely the typical 2-Cys, atypical 2-Cys and the 1-Cys peroxiredoxins classes (Figure 1.8). 
The general catalytic mechanism of peroxiredoxins remains the same for all three classes in 
which a peroxide is reduced to a less toxic form (ROH, either its corresponding alcohol or 
water) and the peroxidatic cysteine is converted to the sulfenic acid intermediate (Cys-SOH) 
(Wood et al., 2003). Although natively occurring as obligate homodimers, the typical 2-Cys 
and the atypical 2-Cys peroxiredoxins have differing resolving steps for oxidized cysteine 
residues. In the case of the typical 2-Cys peroxiredoxin, the oxidized peroxidatic cysteine forms 
an intersubunit disulfide with the resolving cysteine residue of another molecule. Atypical 
2-Cys residues follow a similar mechanism except the resolving cysteine is found on the same 
subunit therefore an intrasubunit disulfide bond is formed. The 1-Cys peroxiredoxin has only 
Figure 1.8: Overview of the three peroxiredoxin mechanisms namely typical 2-Cys, atypical 
2-Cys and the 1-Cys peroxiredoxins. The pink in the diagram represents the resolving cysteine 
from another subunit whereas black represents the peroxidatic cysteine of the same subunit 






the peroxidatic cysteine which is converted to Cp-SOH and thus requires a thiol-containing 
reductant to reduce the Cp-SOH back to Cp-S- (Wood et al., 2003).  
3.3.1. Thioredoxin-dependent thiol peroxidase (Tpx) of Mtb   
Proteome analysis has shown that thiol peroxidase (Tpx) is more abundant than 
catalase/peroxidase (KatG) and AhpC and can be considered to be the leading antioxidant 
defence system in Mtb (Rao and Li, 2009). Thiol peroxidase is regarded as one of the most 
efficient peroxidases of Mtb in terms of its rate constants (Yuniastuti, 2012) for the reactions 
with hydroperoxides (3.3 x 105 M-1.s-1 with TrxB as reductant and 0.9 x 105 M-1.s-1 with TrxC 
as a reductant) and peroxynitrites (1.5 x 107 M-1.s-1) (Jaeger et al., 2004). It is able to reduce a 
wide spectrum of hydroperoxides including hydrogen peroxide which is one of the main threats 
to Mtb cells within the hypoxic granuloma microenvironment. The reduced state is regenerated 
by either TrxB or TrxC of the Mtb thioredoxin system (Jaeger et al., 2004). While thioredoxin 
peroxidase is classified as an atypical 2-Cys peroxiredoxin (Hugo et al., 2012), it behaves as a 
1-Cys peroxiredoxin during peroxynitrite reduction (Trujillo et al., 2006).  
3.3.2. The alkyl hydroperoxidase reductase subunits C, D and E (AhpC, AhpD and AhpE) 
Alkyl hydroperoxide reductases, namely AhpC and AhpE all belong to the peroxiredoxin 
family. AhpC is the largest and most distributed peroxidatic protein with members found in 
archaea, bacteria and eukaryotes and utilize the mode of action of the typical 2-Cys 
peroxiredoxins (Figure 1.8). Mycobacterial AhpC can not only detoxify hydroperoxides but 
also displays reductive capabilities against reactive nitrogen species (RNS) (Guimarães et al., 
2005). Although, functioning as a typical 2-Cys peroxiredoxin, AhpC does in fact have three 
cysteine residues with cysteine 61 being the peroxidatic cysteine, cysteine 174 the resolving 
cysteine and cysteine 176 whose role is unknown but could provide an alternate route for the 
disulfide formation between cysteine residues (Hillas et al., 2000). In enterobacteria, the AhpC 
system consists of alkyl hydroperoxidase sub-unit F (AhpF) as a reductant, but in Mtb the AhpF 
protein is absent and AhpD reductase acts in a comparable role. The AhpC system of Mtb is 
also very malleable in the sense that if AhpD is not available, it can employ TrxC but not TrxA 
or TrxB as reductants (Hugo et al., 2012).  
The final alkyl hydroperoxide reductase to be discussed is alkyl hydroperoxidase sub-
unit E (AhpE), which is found in aerobic gram-positive bacteria such as Actinomycetes and 





hydroperoxide reductase amongst many mycobacterial species and interestingly it has been 
observed that AhpE expression increased during the dormant phase of the tuberculosis disease, 
denoting its role in Mtb latency. Initially the reductant of AhpE was unknown but it was later 
found to utilize the mycothiol pathway in its reduction (Hugo et al., 2014). In this mechanism, 
the active site cysteine residue is oxidized to Cys-SOH by a peroxide or peroxynitrite and 
thereafter a mycothiol molecule reacts with the AhpE-SOH to create a mixed mycothiol 
disulfide AhpE-SS-M. The mixed disulfide is then reduced by Mrx-1 which itself becomes 
mycothionylated, releasing the reduced reactive AhpE. AhpE shows a high specificity towards 
peroxynitrite which it reduces three orders of magnitude faster than hydrogen peroxide (1.9 x 
107 vs 8.2 x 104 M-1s-1 respectively), indicating that it is capable of a broad role in redox defence 
in Mtb survival (Hugo et al., 2012).  
3.3.3. The Bacterioferritin Comigratory Protein (BCP) of Mtb 
The remaining member of the Mtb peroxiredoxin family is the Bacterioferritin 
Comigratory Protein (BCP). A key feature of this protein is that it is a target for modification 
by a small protein named Pup. Pupylation is a post-translational modification that targets 
proteins for degradation by the proteosome itself and plays a role in virulence by mechanisms 
not fully understood (Hugo et al., 2012). BCP is also associated with the membrane fraction of 
Mtb, indicating its role as a possible primary defence able to neutralize threats before they even 
enter the cell (Reyes et al., 2016) and shows structural similarity in its primary structure with 
the yeast peroxiredoxin thiol specific antioxidant protein (TSA) and AhpC indicating it could 
be a novel member of the family. BCP is an atypical 2-Cys peroxiredoxin and exists as a 
monomer under native conditions (Jeong et al., 2000). In Mtb it is a general 
thioredoxin-dependent peroxidase whilst in other organisms has been shown to be more 
efficiently reduced by the glutathione system (Reyes et al., 2016). Mtb BCP, being a general 
peroxidase, shows reductive capabilities towards hydrogen peroxide, t-butyl hydroperoxide 
and linoleic acid hydroperoxide (Clarke et al., 2010; Jeong et al., 2000).  
3.4. KatG, a system dedicated to the neutralization of hydrogen peroxide 
Catalase-peroxidase (KatG) is not a thiol-based antioxidant protein as the previously 
discussed systems, but it is a heme-protein containing a core with an iron center whose main 
role is hydrogen peroxide reduction in Mtb cells (Figure 1.9). It uses the same catalytic 
mechanism as other known catalases in which a hydrogen peroxide molecule is reduced and 





compound I effectively removing two hydrogen peroxide molecules with one catalytic cycle 
(Chouchane et al., 2000). KatG therefore has an increased efficiency at higher hydrogen 
peroxide concentrations. 
One of the more notable characteristics of KatG in Mtb is that it activates the first line 
drug isoniazid (isonicotinic acid hydrazide, INH) which kills drug-susceptible Mtb cells. The 
process of INH activation involves KatG acting upon the INH compound creating the 
isonicotinoyl-acyl-radical which then reacts with NAD+ to create the INH-NADH complex 
which is the active form of the drug. The INH-NADH complex inhibits InhA, an enoyl 
acyl-carrier-protein reductase involved in Mtb cell wall biosynthesis, ultimately leading to loss 
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Figure 1.9. Arrow diagram representation of the redox defence mechanisms within the Mtb cell. These defences include the thioredoxin (Trx) system which links to 
the thiol peroxidase (Tpx, black), alkyl hydroperoxidase subunit C (AhpC, red), bacterioferritin comigratory protein (BCP, purple) and the disulfide between two 
mycothiol known as mycothione (MSSM, orange). Other systems include the catalase/peroxidase system (KatG), AhpE, mycothiol/mycoredoxin-1 system, the 






4. Computational modelling of the Mycobacterium tuberculosis redox defence systems 
The redox defence systems in the Mtb cell that focus on defending against hydrogen 
peroxide were summarized in Figure 1.9. The figure shows the interlinking nature of the 
systems and the central role played by the thioredoxin system which is able to reduce the thiol 
peroxidase, alkyl hydroperoxidase subunit C, bacterioferritin comigratory protein, 
mycothiol/mycothione systems and disulfides in other cellular proteins. It is likely that these 
systems work in conjunction to create a robust defence against hydrogen peroxide with each 
system known to possess varying reaction rates and affinities for this oxidant. The interlinked 
nature of this network argues that computational systems biology could be used to analyse the 
Mtb redox defence network to understand the synergy between these systems. Studying such 
biological networks relies on data generated from three techniques namely genomics, 
proteomics and kinetic modelling. 
4.1. Genomics and its possible applications in Mtb network biology  
Genomics is the study of the molecular organization of genomes, their information 
content and the gene products they encode. Researchers were able to sequence the entire Mtb 
genome (Pagel and Pomiankowski, 2002) and with the aid of bioinformatics tools, more than 
3920 genes were uncovered that encode proteins with a length greater than 80 amino acids with 
additional genes identified for further study and classification. Following sequence analysis, 
roughly 40% of the Mtb genes were assigned precise function and 16% resembled genes with 
no known function (Pagel and Pomiankowski, 2002). Moving forward, various clinical strains 
were isolated from patients and their genomes sequenced. To mention a few, the PR08 (Jaafar 
et al., 2016) and KT-0184 (Kwon et al., 2016) Mtb strains were recently isolated, sequenced 
and analysed. Genome sizes were confirmed around approximately 4.4 Mb in both Mtb strains 
suggesting consistency amongst Mtb’s genetic lineage, now with accurate descriptions being 
given to sub-systems, genes, coding sequences and RNA content of these cells.  
The ability to sequence the entire genome also meant that the genomes of the XDR-TB 
and MDR-TB clinical strains could also be sequenced allowing the identification of biomarkers 
for these strains. Specifically within MDR-TB, an 81 base pair region within the rpoB gene 
enabled the development of a diagnostic test known as Xpert MTB/RIF for the rapid 
identification of clinical specimens along with the detection of rifampicin resistance consistent 
with MDR-TB isolates. The sequences obtained were also sample-specific denoting that the 





transcriptome were also observed during the different stages of the diseases lifecycle (including 
dormant and active stages) (Warner and Mizrahi, 2014). 
Spoligotyping, a PCR based technique relies on the amplification of highly polymorphic 
repeats in the Mtb genome. This makes it a rapid diagnostic test outperforming those such as 
culturing/culture confirmation, susceptibility testing and restriction fragment length 
polymorphism (RFLP) in terms of accuracy, speed and use in quick diagnosis of newly afflicted 
individuals (Gori et al., 2005). Genomics will continue to drive the understanding of 
evolutionary processes and determination of genes of interest in Mtb. Improvement on existing 
software tools will further increase the significance of using genomics in finding new drugs to 
combat diseases by understanding genome network structure (Brazhnik et al., 2002; Warner 
and Mizrahi, 2014).  
4.2. Proteomic analysis and its role in studying Mtb cellular systems 
With the development of proteomics, many new avenues have been opened for TB 
research allowing the study of Mtb proteins along with proteins involved in Mtb-host 
interactions which help the pathogen influence the host immune response and ultimately 
remain viable in a microenvironment designed to be bactericidal. Applications of proteomics 
include searching for potential biomarkers for diagnosis of the disease within the host (in 
combination with genomics), identifying and confirming virulence factors, studying the 
response of both the host and pathogen during the infection process and clarifying the 
mechanisms of action with regard to virulence factors as they interface with host cells (Zhang, 
2011).  
With Mtb proteomics research, the two main technologies used were two-dimensional 
electrophoresis combined with mass spectrophotometry (2DE-MS) or western blotting 
(2DE-WB) and isotope labelling followed with multiple dimensional liquid chromatography 
combined with mass spectrophotometry (LC-MS) analysis (Schubert et al., 2015). The 
development of a label-free method based on one dimensional separation was achieved by 
LC-MS identification followed by exponentially modified protein abundance index (emPAI) 
quantification which was used to identify differentially abundant proteins in closely related 
hypo- and hyper-virulent clinical Mtb strains (Zhang, 2011).  
These methods along with characterization of multiple proteins allowed the identification 





(Kinnings et al., 2010). The drugome was created with the purpose of identifying possible drug 
targets within molecular interaction networks based on binding sites and biochemical 
interactions between cellular components. It includes not only the primary targets of the drug 
but also potential off-targets in the network, successfully providing opportunities for mapping 
a comprehensive drug-target space to aid in understanding drug efficacy, side-effects and drug 
resistance possibilities on a molecular basis (Kinnings et al., 2010; Mehaffy et al., 2012).  
A challenge for proteomic studies is that the analysis of low-abundance proteins remains 
a major problem. In addition, most of the methods used for proteomics studies are not 
considered high-throughput and for this reason cannot be studied on the same scale as nucleic 
acids, making it time consuming (Graves and Haystead, 2002). There additionally exists a 
trade-off between throughput and accuracy and while many samples can be analysed in an 
automated fashion using MALDI-TOF for example, the quality is sacrificed and many proteins 
are not identified. Alternatively, fewer samples could be analysed using tandem mass 
spectrometry (MS/MS) but this method requires considerable time in data interpretation. 
Despite these shortcomings, proteomic studies, when combined with molecular biology, still 
have the potential to provide enormous insight into the biology of many organisms’ intra- and 
extra-cellular protein networks (Graves and Haystead, 2002).  
4.3. Systems biology computational modelling approaches 
Genomics, proteomics and traditional biochemistry techniques provide data about gene 
and protein networks and their interactions which can be compiled to create kinetic models for 
use in computational systems biology. Researchers can use high throughput technologies and 
utilize data generated to cover the entire system for a ‘top-down’ approach whilst others can 
work from molecules to functional modules in a ‘bottom-up’ approach. A newer method named 
the ‘middle-out’ strategy involves starting from tissue models and working up to the organ and 
higher levels as well as down to the molecular details. In general, systems biology could be 
considered the application of dynamic systems theory in biology (Mendoza, 2009). The 
systems biology computational modelling approach can be further broken down into 








4.3.1. Genome-scale modelling vs kinetic modelling approaches 
Genome scale models take into account the interconnected nature of metabolites, 
enzymes and regulatory factors creating a model, usually focusing on the metabolic pathways 
of a cell. This technique allows the creation of a mathematical model that links cellular aspects 
of the same time scale and simulates the reactions as they would occur in vivo. It provides an 
access point for precisely analysing cellular phenotype by simulating changes in genetic, 
regulatory, enzymatic and small molecule levels which are practically impossible to do in vivo 
due to the enormous amount of variables within a genome scale model. Hence, these models 
are broken into their sub-systems and studied further to get a more detailed understanding of 
the interactions taking place within the bigger superstructure of the metabolic and / or 
regulatory networks (Blazeck and Alper, 2011).  
Genome scale models include information from previously conducted experiments 
pertaining to the study (genomics and proteomics) and obtain additional or missing parameters 
and validation of said parameters and reactions from literature sources as well as pre-existing 
models. Pre-existing models refer to those models previously used to understand and analyse 
the system in question. This could also be a model which is incomplete or has components that 
are present in the system within the current study. From this information a ‘draft’ model is 
constructed which is then simulated and manually curated to alter the model to a realistic result. 
There are also a wide range of external resources that aid in genome-scale model construction 
such as AUTOGRAPH (semi-automated approach to accelerate the curation process), BiGG 
(biochemical, genetic and genomically structured genome-scale metabolic network 
reconstructions), BioCyc (collection of >1000 pathway/genome databases), BRENDA 
(collection of enzyme functional data) and KEGG (Kyoto Encyclopaedia of Genes and 
Genomes, bioinformatics resource links genomes to pathways) to mention a few (Santos et al., 
2011). Genome models are not without disadvantages, as they do not cover the total metabolic 
pool found within the cell. Further, these models share the structure and stoichiometry 
characteristics of reactions with kinetic models but leave out almost all of the kinetic details. 
They also provide a “context for content” explanation implying they give a general overview 
of the system by providing details of the major fluxes within a system as opposed to a bottom-
up kinetic model which can provide detailed flux information for all reactions within a model. 
Genome-scale models have however been proved to be useful in large data integration 
(reconstruction of transcription regulation networks, signal transduction networks and the 





Mycobacterium tuberculosis H37Rv on the various databases outlined below. For example, a 
comprehensive and detailed model describing Mtb H37Rv metabolism can be found on the 
Biochemical, Genetic and Genomic knowledge (BiGG) database describing 825 metabolites, 
1025 reactions and 661 genes of interest within this model (http://bigg.ucsd.edu). 
Kinetic models on the other hand are similar to genome scale models in the context that 
they are set up similarly (similar reaction schemes). Kinetic models (bottom-up strategy) take 
into account majority of the details of the system and rarely include a genome-scale survey of 
information as is the case with genome-scale models. The details of a kinetic model allows for 
the dynamics of the system to be explored as well as control the structure of the pathway. Once 
a model is created or made available for use, parameters and conditions can be altered to study 
biologically relevant properties such as homeostasis. This characteristic of the kinetic models 
allows a researcher to manipulate pathways in silico and ultimately study the changes in 
behaviour of that system (Santos et al., 2011). Top-down systems biology starts from the bird’s 
eye view of the behaviour of the system by measuring genome-wide experimental data and 
aims to characterize the sub-systems comprising the larger superstructure and their respective 
interactions (Bruggeman and Westerhoff, 2007). Top-down kinetic modeling therefore takes 
into account the various components of the larger network and searches for correlations 
between the different variables of the system. Examples of this approach include predicting a 
particular limitation or stress during the fermentation process or to predicting the likely 
outcomes of therapeutic agents used in disease studies (Santos et al., 2011). 
Kinetic models have been used successfully but also face a number of serious limitations 
(Materi and Wishart, 2007). First, kinetic parameters of all enzymes in a pathway are not 
always available, even with databases like BRENDA and Sabio-RK. The available parameters 
are also frequently determined at experimental optimum conditions instead of the physiological 
conditions of the organism. Second, these models represent relatively small and isolated 
metabolic pathways which are themselves embedded in a larger metabolic network. Boundary 
conditions are thus needed (the exchange of information with the rest of the larger system) and 
becomes important in the prediction of the models results. It has been shown that including the 
boundary information, even uncertain values, can drastically improve the predictive power of 
the kinetic models (Santos et al., 2011).  
The various approaches (genome-scale modelling, bottom-up and top-down kinetic 





often dependent on the expertise of user (software choice), the type of desired output, the 
knowledge of the model parameters (complete or incomplete sets of values) and the complexity 
of the system to be modelled. This gives the user freedom in terms of research but warrants 
caution as the type of results obtained are entirely dependent on the values used to construct 
the computational models. Consequently, utmost care needs to be exercised in extracting 
information from various sources so that the most accurate kinetic computational model can be 
constructed with the most realistic and comprehensive results possible (Materi and Wishart, 
2007).     
5. Conclusion 
 Despite having vast amounts of literature and data regarding the individual redox 
defence proteins of Mtb, a comprehensive and holistic understanding of the redox network is 
still lacking. There currently exist no kinetic models to describe the Mtb redox defence system 
particularly in the hyperoxic microenvironment of the lung. The aim of this research was to 
therefore accurately data mine literature, create an accurate and comprehensive wire diagram 
of the Mtb redox defence network, with focus on hydrogen peroxide, and subject the network 
to structural motif detection and kinetic model analysis so that this systems’ behaviour could 
be analysed to determine the roles played by the various redox proteins with regard to Mtb 













Chapter 2: Structural analysis of the Mycobacterium tuberculosis redox 
defence network reveals a unique bi-fan motif design in hydrogen peroxide 
defence 
2.1 Introduction 
Biological reductionism has allowed the cellular components of complex networks to be 
analyzed individually, providing a vast amount of information on their intra- and extra-cellular 
function (Barabási and Oltvai, 2004). The networks created by these cellular components 
coordinate cell growth, replication, defence strategies and mobility to name a few. The redox 
defence networks of cells consists of peroxiredoxins, thioredoxins, catalases and 
low-molecular-weight thiols such as mycothiol (with respect to mycobacteria) or glutathione. 
The interactions between these molecules creates a cascade of electron flow originating at 
either NADPH or NADH which ultimately provides electrons to reduce toxic compounds like 
hydrogen peroxide and recycle oxidized proteins (Rustad et al., 2008; Nelson and Parsonage, 
2013). For pathogens such as M. tuberculosis, the redox network allows its survival for up to 
decades in its latent form within its host (Kumar et al., 2011). Dissection of this network could 
reveal topological patterns, referred to as motif designs that can shed light on various 
network/system functions based on the multiple protein interactions within the network (Wong 
et al., 2012). 
In this chapter, the set of network motifs in the redox defence networks of 
M. tuberculosis, E. coli and S. cerevisiae were compared. Network motifs are statistically 
significant, over-represented sub-graphs contained in the larger superstructure of the network 
(Tran et al., 2015). In practice, network motifs are detected by comparing test networks against 
randomized networks and therefore motifs that are detected represent a specific function within 
the cell and will provide more information towards system organization (Yeger-Lotem et al., 
2004). The idea of motifs was originally introduced by Uri Alon and co-workers who studied 
them in biological and non-biological networks (Milo et al., 2002). Motifs can be detected in 
numerous cellular networks and can be used to classify these individual networks (Dobrin et 
al., 2004). Motifs themselves consist of unique sets of nodes or vertices, representing the 
individual entities within the network (e.g. proteins), connected by edges (e.g. reactions) which 
themselves can be either directed or undirected. The connections between the edges and nodes 
within each of the motifs can be used to characterize a particular motif. Motif sizes range from 





motifs come from a set of 13 different sub-graphs while four node motifs come from a set of 
199 (Milo et al., 2002). These connections can be further classified into specific categories: 
cycles (flow from one node to the next, closing in on itself), feed-forward loops (FFL, contains 
one direct path to the target node and a path involving an intermediate node leading to the same 
target node), single (one node linking to various other target nodes) and multiple (multiple 
nodes linking to various other target nodes) input modules (SIM and MIM respectively). For 
example, a bi-fan motif which is a type of multiple input module, contains exactly two start 
(parent) nodes and two end (child) nodes (for examples see Milo et al., 2002; Konagurthu and 
Lesk, 2008).  
Motif detection has been applied to numerous networks including protein-protein 
interactions of S. cerevisiae (Yeger-Lotem et al., 2004), the transcription network of E. coli 
(Konagurthu and Lesk, 2008), the Caenorhabditis elegans neural network (Tran et al., 2015), 
the World Wide Web, electronic circuits, food webs and social networks (Milo et al., 2002). 
This chapter focuses on the application of motif detection on the M. tuberculosis redox defence 
network to further understand how its defence system proteins are functionally organized with 
the goal of finding new drug targets. To aid in this analysis, the M. tuberculosis redox defence 
network was compared to the canonical E. coli and S. cerevisiae redox defence networks. 
2.2 Methods  
2.2.1 Wire diagram construction and motif detection within the Mtb redox network 
Wire diagrams were constructed for hydrogen peroxide (H2O2) reduction redoxin 
networks in all three organisms using information from literature. To simplify analysis, the 
redox couples and their respective reductase enzymes were each described as individual nodes 
(see also Rohwer et al., 2016). The wire diagrams were focused on the hydrogen peroxide 
reduction network in the cell and included all known redox defence proteins specific to this 
task. Text files (extension .txt) were created in SciTE (Scintella Text Editor) converting the 
wire diagram information into a text file format for use in the motif detection programs. The 
files followed the format: 
<Node 1> <Node2>, 
where Node 1 represents the parent node and Node 2 represents the child node which indicated 





The text files contained NADPH, NADH and hydrogen peroxide as individual nodes as 
these are the boundaries of the systems. The text files were then loaded and analyzed using two 
programs, MAVisto (Version 2.7.0) (Schreiber and Schwöbbermeyer, 2005) and FANMOD 
(Fast Network Motif Detection) (Wernicke and Rasche, 2006).   
For MAVisto, the file was uploaded and allowed to run using the default motif search 
settings for both three and four node motif detections and each case 2000 randomizations were 
used. The program allowed for immediate visualization of results and network motifs were 
detected, displayed and then exported for later analysis. MAVisto and FANMOD name the 
motifs detected based on their own predesigned library. For example in MAVisto, the motif ID 
2F represents the common two node motif, parent node leading to child node. For each motif, 
a Z-score, P-value, mean frequency and standard deviation was determined (Appendix). 
FANMOD (Rasche and Wernicke, 2006)  was used to confirm the results obtained from 
MAVisto. The program was used in a similar fashion and sub-graph sizes of three and four 
were once again detected for each individual organism with the option ‘full enumeration’ 
selected along with the ‘directed’ sub-graph option. To keep analysis consistent, 2000 
randomizations were used with 3 ‘exchanges per edge’ and ‘exchange attempts’. The option to 
‘re-estimate sub-graph number’ was selected for greater accuracy (Rasche and Wernicke, 
2006). Results were visualized using the ‘HTML-export’ function, opening a web browser to 
view the FANMOD predesignated motif ID, frequency (original network), mean-frequency of 
the random networks, standard deviation, Z-score, P-value and the sub-graph image 
(Appendix).  
For the purpose of this study, although the Z-scores and P-values are obtained (Appendix) 
for the motif designs detected within the three networks, they have not been looked at further 
due to the small size of the networks. Motif detection was carried out to simply identify the 
different 3 and 4 node motif designs within the networks to identify unique motifs that could 
be attributed to Mtb latency and survivability within the host granuloma microenvironment. 
2.2.2 Analytical solutions and kinetic model simulations for unique bi-fan motif in 
M. tuberculosis 
Analytical solutions were derived for the bi-fan and control bi-parallel motif designs. In 
all cases, mass action kinetic expressions were used to derive these analytical solutions (Pillay 
et al., 2011). All model simulations were done using the Python Simulator for Cellular Systems 





(Appendix) to take into account each reaction’s properties such as rate constants and fixed 
species concentrations. Each particular motif script file was then simulated in Jupyter Notebook 
and Matplotlib (http://matplotlib.org) was used for graph construction and visualization as 
described previously (Pillay et al., 2011 and Rohwer et al., 2016).  
2.3 Results 
2.3.1 Wire diagram construction of the M. tuberculosis redox defence network 
Wire diagrams of the redox defence networks of M. tuberculosis, E. coli and S. cerevisiae 
were constructed mapping the various protein interactions within each of the three redox 
networks. Protein interactions were deduced from literature although one protein, 
M. tuberculosis BCP (MtBCP), lacked characterization. To elucidate the interactions between 
BCP and other proteins in the redox network, two questions were answered using 
bioinformatics tools. First, which peroxiredoxin catalytic mechanism does BCP follow, and 
second, will Mtb thioredoxins be able to reduce the oxidized peroxiredoxin?  
2.3.1.1 Does MtBCP follow a 1- or 2-Cys peroxiredoxin reaction mechanism? 
Sequence analysis of the MtBCP amino acid (Rv2521, TBDB: www.tbdb.org) reveals 
that the MtBCP has two cysteine residues in a conserved -TPGCXXXXC- catalytic motif when 
aligned with the E. coli BCP (Figure 2.1). The conservation of the catalytic motif suggests that 
the MtBCP will follow the atypical 2-Cys reaction scheme (Figure 2.2) (D’Ambrosio et al., 
2009).  
 
Figure 2.1. Amino acid sequence alignment between the Mtb BCP and the E. coli BCP reveals 
that the Mtb BCP (Rv2521) contains a catalytic -TPGCXXXXC- motif (Outlined in red) and 






Figure 2.2. A proposed reaction scheme for Mtb BCP. The red sulfur residues indicate oxidized 
species, which are in turn reduced by the NADPH/thioredoxin reductase/thioredoxin system. 
2.3.1.2 Which of the three thioredoxins of Mtb would be able to reduce Mtb BCP? 
The genome of Mtb encodes for three thioredoxin proteins i.e. TrxA, TrxB and TrxC. 
Sequence alignment amongst these three thioredoxin proteins reveals that TrxA deviates from 
the conserved thioredoxin catalytic motif, which is -WCXXC-, whilst TrxB and TrxC both 
contain the conserved motif (Figure 2.3, outlined in red). This is supported by other studies 
showing that Mtb TrxA is cryptic and not biologically active (Akif et al., 2008). In TrxA, the 
substitutions of tryptophan (W) to leucine (L) and glycine (G) to alanine (A) could explain loss 
of protein function as glycine and tryptophan are specifically linked to conservation of catalytic 
protein function such as thioredoxins (Holmgren, 1995; Parrini et al., 2005; Barnes, 2007).  
 
Figure 2.3. Multiple amino acid sequence alignment between the three Mtb thioredoxins (TrxA, 
TrxB and TrxC) and the E. coli thioredoxin reveals the conserved -WCXXC- catalytic motif 
amongst Mtb TrxB, TrxC and E. coli Trx (outlined in red). Mtb TrxA deviates from the 
conserved -WCXXC- catalytic motif suggesting loss of activity in vivo is a result of amino acid 
substitutions around the protein active site. 
In the wire diagram constructed for Mtb, TrxB and TrxC are both are possible sources of 








Figure 2.4. Construction of the redox defence networks of (A) M. tuberculosis, (B) E. coli and 





were constructed to represent interactions between proteins and to analyze similarities and 
differences amongst redox defence networks of the model organisms against M. tuberculosis. 
Red shading (A) indicates the bi-fan motif of M. tuberculosis whilst the blue (A, B and C) 
indicates the presence of a feed-forward loop. Key: NADPH, nicotinamide adenine 
dinucleotide phosphate; NADH, nicotinamide adenine dinucleotide; H2O2, hydrogen peroxide; 
MR, mycothiol disulfide reductase; MSH, mycothiol; Mrx1, mycoredoxin-1; AhpE, alkyl 
hydroperoxidase sub-unit E; katG, catalase-peroxidase; TR, thioredoxin reductase; TrxB/C, 
thioredoxin B and C; BCP, bacterioferritin comigratory protein; Tpx, thiol peroxidase; LPD, 
lipoamide dehydrogenase (Rajashankar et al., 2005); DlaT, dihydrolipoamide acyltransferase 
(Voskuil et al., 2011); AhpD, alkyl hydroperoxidase sub-unit D; AhpC, alkyl hydroperoxidase 
sub-unit C; GSH, glutathione (Jothivasan and Hamilton, 2008; Rawat and Av-Gay, 2007); Gpx, 
glutathione peroxidase (Arenas et al., 2011 and Inoue et al., 1999); Grx, glutaredoxin (Arenas 
et al., 2011 and Inoue et al., 1999); AhpF, alkyl hydroperoxidase sub-unit F (Brandes et al., 
2007); PSS, protein disulfide; Prx1, peroxiredoxin-1 (Greetham and Grant, 2009); Tsa1/2, 
thiol-specific antioxidant protein 1 and 2 (Herrero et al., 2008); Ahp1, alkyl hydroperoxidase 
1 (Lee et al., 1999); Dot5, nuclear Tpx-BCP like (Herrero et al., 2008); Cta1, peroxisome 
catalase (Jamieson, 1998); Ctt1, cytoplasmic catalase (Jamieson, 1998). 
2.3.2 Motifs detected in the M. tuberculosis H2O2 reduction defence network 
The three wire diagrams for M. tuberculosis, E. coli and S. cerevisiae (Figure 2.4 A-C) 
were analyzed by motif detection analysis for three and four node connections. As mentioned 
above, the different connections within a system contribute to the properties of that particular 
system which could shed light on the individual roles of isolated pathways in the network 
superstructure. Using MAVisto and FANMOD motif detection programs, a number of 
common three node motifs were detected (Table 2.1) with the Z-score, P-value and frequency 











Table 2.1. Common three node motifs in the hydrogen peroxide reduction networks of M. tuberculosis, 
E. coli and S. cerevisiae generated by both FANMOD and MAVisto motif detection programs. 
Canonical Motif ID Motif 
connections  
Absence/Presence in species 














































For the three node sub-graphs, all three organisms had a similar set of motifs (Table 2.1). 
Generally, the presence of the same set of motifs suggests positive selection for these 
interaction patterns because of their functional and structural properties (Tran et al., 2015). The 
simplified single input module (motif ID: 6/F7F); a uni-directional pathway with one node 
leading to another which in turn leads to the next (motif ID: 12/F8R); simplified multiple input 
module (two nodes leading to one, motif ID: 36/GCR) and the feed-forward loop (motif 
ID: 38/FKX) were detected in the redox defence systems of all three organisms albeit with 
varying frequencies (see Figure 2.5, 2.6 and Appendix). This suggests that these motif designs 
are favored for hydrogen peroxide reduction compared to other three node motif designs.  
 
Figure 2.5. Frequencies of the common three node motifs detected for M. tuberculosis, E. coli 


































Figure 2.6. Frequencies of the common three node motifs detected for M. tuberculosis, E. coli 
and S. cerevisiae detected using FANMOD.  
By contrast, the analysis of the four node sub-graphs showed both common and unique 
motif designs suggesting variation in these systems’ capacities to reduce hydrogen peroxide. 
The 14 four node motifs detected once again included single input modules (e.g. motif 
ID: 14/PMN4F); multiple input modules (e.g. motif ID: 2184/Q9PFR); simple pathways with 
nodes leading to one another (e.g. motif ID: 392/RJ9KF) and adaptations of the feed-forward 
loop (e.g. motif ID’s: 2076/Q9GBX and 2188/Q9QK9) (Table 2.2) with varying frequencies 
across the three redox networks (Figure 2.7 and 2.8). Most of the motif designs were shared 
across all three species, again suggesting that these motif designs are sufficient in redox 
networks centered on hydrogen peroxide reduction (Table 2.2). 
However, with respect to M. tuberculosis, two unique motif patterns were observed i.e. 
motif ID: 204/PMRM9 and 2118/PMYH9 (Table 2.2, shaded red and blue respectively). The 
latter motif is present due to connections between AhpE, MSH and Mrx-1 for reducing 
hydrogen peroxide, with AhpE being the node leading to and responsible for hydrogen 
peroxide reduction (Figure 2.4 A, blue highlight). Motif ID: 204/PMRM9 (known as the bi-fan 
motif), was particularly intriguing because this motif design arises from the wiring or 
connecting of the thioredoxins TrxB and TrxC with the peroxiredoxins Tpx and BCP (Figure 
2.4 A, red highlight). As the M. tuberculosis thioredoxin system reduces two of the four 


































Table 2.2. Common and unique four node motifs in the hydrogen peroxide reduction networks of 
M. tuberculosis, E. coli and S. cerevisiae generated by both FANMOD and MAVisto motif detection 
programs. 
Canonical Motif ID Motif 
connections 
Absence/Presence in species 
FANMOD MAVisto Mtb E. coli S. cerevisiae 































































































































































Figure 2.7. Frequencies of the common and unique four node motifs detected for 
M. tuberculosis, E. coli and S. cerevisiae detected using MAVisto. 
 
Figure 2.8. Frequencies of the common and unique four node motifs detected for 


























































2.3.3 Analytical solutions solved for the bi-parallel and unique bi-fan motif of Mtb 
To understand the role of the unique bi-fan motif in the M. tuberculosis redox network, 
the properties of the bi-fan motif were compared to a bi-parallel motif (Figure 2.9) which served 
as the control for this analysis and is not present in any of the current redox networks being 
studied. The bi-fan motif comprising TrxB, TrxC, Tpx and BCP were connected to NADPH 
and hydrogen peroxide which were treated as fixed boundaries of the system. 
 
 
Figure 2.9. Diagrammatic representation of the bi-parallel motif (A) and the bi-fan motif (B). 
Each of the nodes represents a moiety couple, i.e. the coupling of the reduced and oxidized 
forms into a single node. The crossing of the black (TrxC arm of the motif) and red (TrxB arm 
of the motif) arrows in (B) shows that two thioredoxins are responsible for the simultaneous 
reduction of two peroxiredoxins. 
Analytical solutions for the bi-fan and bi-parallel motifs were evaluated using mass 
action kinetics as described previously (see Pillay et al., 2011). Scheme I below describes the 
reactions pertaining to the TrxB-dependent reactions of the bi-parallel motif. For the analytical 
solutions, the nodes were described by their reduced (SH) and oxidized forms (SS). The rates 
of the TrxB-dependent reactions of the bi-parallel motif can be described by rate equations 1-3 
while the sum of the TrxB moiety couple is described by equation (4). 
Scheme I: the bi-parallel motif (Figure 2.9A) 
𝑣1  =  𝑘1. 𝑁𝐴𝐷𝑃𝐻. 𝑇𝑟𝑥𝐵𝑆𝑆    (1) 
𝑣2  =  𝑘2. 𝑇𝑟𝑥𝐵𝑆𝐻. 𝑇𝑝𝑥𝑆𝑆    (2) 
𝑣3  =  𝑘𝑐1. 𝑇𝑝𝑥𝑆𝐻. 𝐻2𝑂2    (3) 





The rates of the TrxC-dependent reactions of the bi-parallel motif can similarly be described 
by the following rate equations (equations 5-7). The sum of the TrxC moiety couple is 
described by equation (8).  
𝑣4 = 𝑘4. 𝑁𝐴𝐷𝑃𝐻. 𝑇𝑟𝑥𝐶𝑆𝑆               (5)   
𝑣5 = 𝑘5. 𝑇𝑟𝑥𝐶𝑆𝐻. 𝐵𝑐𝑝𝑆𝑆    (6)  
𝑣6 = 𝑘𝑐2. 𝐵𝑐𝑝𝑆𝐻. 𝐻2𝑂2    (7)  
𝑇𝑟𝑥𝐶𝑡𝑜𝑡𝑎𝑙 = 𝑇𝑟𝑥𝐶𝑆𝐻 + 𝑇𝑟𝑥𝐶𝑆𝑆     (8) 
where v1, v2, v3, v4, v5 and v6 are the rates of reactions; k1, k2, k4, k5, kc1 and kc2 are the rate constants 
and capitalized species names are the concentrations of the reactants. At steady-state, 𝑣1 = 𝑣2 
and therefore: 
𝑘1.  𝑁𝐴𝐷𝑃𝐻. (𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑎𝑙 − 𝑇𝑟𝑥𝐵𝑆𝐻)  = 𝑘2. 𝑇𝑟𝑥𝐵𝑆𝐻. 𝑇𝑝𝑥𝑆𝑆    (9) 
This expression can be rearranged to yield: 
𝑇𝑟𝑥𝐵𝑆𝐻 =  
𝑘1.𝑁𝐴𝐷𝑃𝐻.𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑎𝑙
𝑘2.𝑇𝑝𝑥𝑆𝑆+𝑘1.𝑁𝐴𝐷𝑃𝐻
               (10) 
Substituting equation (10) into equation (2) gives equation (11) which has the same form as 
the Michaelis-Menten equation: 
          𝑣2 = 𝑘2. 𝑇𝑟𝑥𝐵𝑆𝐻. 𝑇𝑝𝑥𝑆𝑆  
          𝑣2 = 𝑘2. (
𝑘1. 𝑁𝐴𝐷𝑃𝐻. 𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑎𝑙
𝑘2. 𝑇𝑝𝑥𝑆𝑆 + 𝑘1. 𝑁𝐴𝐷𝑃𝐻
) . 𝑇𝑝𝑥𝑆𝑆 





             (11) 
where k1.NADPH.TrxBtotal is the apparent Vmax, 
𝑘1
𝑘2
. 𝑁𝐴𝐷𝑃𝐻 is the apparent Km and TpxSS is 
the oxidized peroxiredoxin substrate in question. The TrxC mediated reduction of BCP (Figure 
2.9 A right, black arrows) follows a similar solution with the TpxSS being substituted for 
BcpSS.  
This result shows that reduction of single peroxiredoxin is limited to its respective 
cognate thioredoxin, i.e. Tpx is reduced by TrxB and BCP is reduced by TrxC and these 
reactions have no direct effect on each other. Ordinary differential equations were then used to 
determine the effect of thioredoxin on the 𝑇𝑝𝑥𝑆𝑆 concentration. 𝑇𝑝𝑥𝑆𝑆 is produced and 








= 𝑣3 − 𝑣2  





)              (12) 
Solving for 𝑇𝑝𝑥𝑆𝐻 at steady-state yields:  
           𝑇𝑝𝑥𝑆𝐻 =  
(𝑘1.𝑘2.𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑎𝑙.𝑁𝐴𝐷𝑃𝐻).(𝑇𝑝𝑥𝑆𝑆)
𝑘𝑐1.𝐻2𝑂2.(𝑘1.𝑁𝐴𝐷𝑃𝐻+𝑘2.𝑇𝑝𝑥𝑆𝑆)
             (13) 
Similarly, the steady-state BCP concentration can be determined by equation (14):  
𝐵𝑐𝑝𝑆𝐻 =  
(𝑘4.𝑘6.𝑇𝑟𝑥𝐶𝑡𝑜𝑡𝑎𝑙.𝑁𝐴𝐷𝑃𝐻).(𝐵𝑐𝑝𝑆𝑆)
𝑘𝑐2.𝐻2𝑂2.(𝑘4.𝑁𝐴𝐷𝑃𝐻+𝑘6.𝐵𝑐𝑝𝑆𝑆)
                  (14) 
These results further demonstrate that the activities of both BCP and Tpx are only 
affected by their cognate thioredoxin and not the thioredoxin of the parallel arm. However, 
these steady-state concentrations depend on the NADPH, thioredoxin reductase (𝑣4 and 𝑣1) 
and hydrogen peroxide concentrations and therefore BCP and Tpx can indirectly affect each 
other’s steady-state concentrations and activity. This result implies that if the NADPH and 
thioredoxin reductase concentrations were not limiting, the two arms of the bi-parallel motif 
will reduce hydrogen peroxide independently of one another. Further, if either TrxB or TrxC, 
or Tpx or BCP were inactive, the reductive flux of hydrogen peroxide could continue through 
the active arm of the motif. 
A similar approach was taken in solving the equations for the bi-fan motif (Figure 2.9 B), 
although the bi-fan motif contains two additional reactions, i.e. TrxB reducing BCP and TrxC 
reducing Tpx (Figure 2.9 B). The system of reactions can be described with the following rate 
equations (15-22): 
Scheme II: the bi-fan motif (Figure 2.9B): 
𝑣1 = 𝑘1. 𝑇𝑟𝑥𝐵𝑆𝑆. 𝑁𝐴𝐷𝑃𝐻                  (15) 
𝑣2 = 𝑘2. 𝑇𝑟𝑥𝐵𝑆𝐻. 𝑇𝑝𝑥𝑆𝑆                  (16) 
𝑣3 = 𝑘3. 𝑇𝑟𝑥𝐵𝑆𝐻. 𝐵𝑐𝑝𝑆𝑆                                                               (17) 
𝑣4 = 𝑘4. 𝑇𝑟𝑥𝐶𝑆𝑆. 𝑁𝐴𝐷𝑃𝐻                  (18) 
𝑣5 = 𝑘5. 𝑇𝑟𝑥𝐶𝑆𝐻. 𝑇𝑝𝑥𝑆𝑆                  (19) 
𝑣6 = 𝑘6. 𝑇𝑟𝑥𝐶𝑆𝐻. 𝐵𝑐𝑝𝑆𝑆                                                               (20) 
𝑣7 = 𝑘𝑐1. 𝑇𝑝𝑥𝑆𝐻. 𝐻2𝑂2                  (21) 





At steady-state, 𝑣1 = 𝑣2 + 𝑣3 and can be expressed as follows: 
𝑘1. 𝑇𝑟𝑥𝐵𝑆𝑆. 𝑁𝐴𝐷𝑃𝐻 = 𝑘2. 𝑇𝑝𝑥𝑆𝑆. 𝑇𝑟𝑥𝐵𝑆𝐻 + 𝑘3. 𝐵𝑐𝑝𝑆𝑆. 𝑇𝑟𝑥𝐵𝑆𝐻                          (23) 
Rearranging and solving for 𝑇𝑟𝑥𝐵𝑆𝐻 yields the following equation: 
𝑇𝑟𝑥𝐵𝑆𝐻 =  
𝑘1.𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑎𝑙.𝑁𝐴𝐷𝑃𝐻
𝑘1.𝑁𝐴𝐷𝑃𝐻+𝑘3.𝐵𝑐𝑝𝑆𝑆+𝑘2.𝑇𝑝𝑥𝑆𝑆
                   (24) 
Substituting equation (24) into equation (16) yields: 
𝑣2 =  𝑘2. 𝑇𝑟𝑥𝐵𝑆𝐻. 𝑇𝑝𝑥𝑆𝑆  





                  (25) 
When compared to the bi-parallel motif (equation 11), the rate of Tpx reduction (equation 25) 
now incorporates the term 𝑘3. 𝐵𝑐𝑝𝑆𝑆 into the denominator showing that the rate of reaction 𝑣2 
is dependent on the rate of reduction of BcpSS by TrxBSH. The solution for TrxCSH and 𝑣5 
can be similarly analyzed to yield the following expression:  





                   (26) 
The ordinary differential equation for reduced Tpx can be obtained as follows: 
𝑑𝑇𝑝𝑥𝑆𝑆
𝑑𝑡
=  𝑣7 − 𝑣2 − 𝑣5  
                       =  𝑘𝑐1. 𝐻2𝑂2. 𝑇𝑝𝑥𝑆𝐻 − 𝑣2 − 𝑣5                  (27) 
where 𝑣2 𝑎𝑛𝑑 𝑣5 are equations (25) and (26) respectively, showing the utilization or removal 
of TpxSS, and the expression 𝑘𝑐1. 𝐻2𝑂2. 𝑇𝑝𝑥𝑆𝐻 is the production of TpxSS.  
However, the steady-state solution for equation (27) was extremely complex and did not 
shed any insights into this system’s configuration (Appendix, equation S1). In summary, unlike 
the bi-parallel solution (equation 11), the bi-fan analytical solution (equations 25-26) includes 
both peroxiredoxins in both rate expressions showing that the rate of TpxSS reduction is 
affected by the reduction of BcpSS and vice versa. Further, a single thioredoxin, TrxB or TrxC, 
is sufficient for hydrogen peroxide reduction via either arm of the motif. The bi-fan analytical 
solution (equations 25-26) also implied that Tpx and BCP affect each because they directly 
share a reductive source, i.e. either TrxB or TrxC. However, this trade-off in the system means 





active. The complexity of the differential equations for the bi-fan motif prompted kinetic model 
simulations to be carried out to further understand the trade-offs within the bi-fan motif system.  
2.3.4 Core model simulations to determine dynamics of the bi -parallel and –fan motifs 
Core models of the bi-parallel and bi-fan motifs were developed in Jupyter Notebook 
using PySCeS, with model parameters set to one (Tables 2.3 and 2.4) so that the steady-state 
properties of these differing connectivities could be explored. The behavior of these models 
was analyzed to determine if the systems behaved as predicted by their analytical solutions. 
Table 2.3. Species concentrations used for the core computational models of the bi-parallel and bi-fan 
motif designs.  




















Thioredoxin reductase (TR) 
 
5 b 
Thioredoxin B red (TrxBSH) 
 
0.5 a 
Thioredoxin B ox (TrxBSS) 
 
0.5 a 
Thioredoxin C red (TrxCSH) 
 
0.5 a 
Thioredoxin C ox (TrxCSS) 
 
0.5 a 
Thiol peroxidase red (TpxSH) 
 
0.5 a 








protein ox (BcpSS) 
 
0.5 a 
H2O2 1 b 
a Note that the concentrations of moiety conserved couples together equal 1. 













Table 2.4. Reactions and reaction parameters for core computational modeling of both the bi-parallel 
and bi-fan motif. 
Reaction Parameter Value 
Both models (thioredoxin reductase reaction scheme) 
 
R1: NADPH + TrxBSS  NADP + TrxBSH kcat1 1 s-1 




R2: NADPH + TrxCSS  NADP + TrxCSH kcat2  1 s-1 
 K1nadph 1 µM 
 K2trxcss 1 µM 
 
Bi-parallel motif script 
 
R3: TrxBSH + TpxSS  TrxBSS + TpxSH k3 1 µM-1.s-1  
 
R4: TpxSH + H2O2  TpxSS + 2 H2O  k4 1 µM-1.s-1  
 
R5: TrxCSH + BcpSS  TrxCSS + BcpSH k5 1 µM-1.s-1 
 
R6: BcpSH + H2O2  BcpSS + 2 H2O k6 1 µM-1.s-1 
 
Bi-Fan motif script 
 
R3: TrxBSH + TpxSS  TrxBSS + TpxSH k3 1 µM-1.s-1 
 
R4: TrxBSH + BcpSS  TrxBSS + BcpSH k4 1 µM-1.s-1 
 
R5: TrxCSH + TpxSS  TrxCSS + TpxSH k5 1 µM-1.s-1 
 
R6: TrxCSH + BcpSS  TrxCSS + BcpSH k6 1 µM-1.s-1 
 
R7: TpxSH + H2O2  TpxSS + 2 H2O k7 1 µM-1.s-1 
 
R8: BcpSH + H2O2  BcpSS + 2 H2O k8 1 µM-1.s-1 
 
 
Although the thioredoxin reductase concentration was similar between models, the flux 
through the bi-fan system was higher over a range of hydrogen peroxide concentrations when 
compared to the bi-parallel motif (Figure 2.10) suggesting that the saturation in both models 
may have resulted from a saturation of the moiety couples in the system (Pillay et al., 2009; 
Padayachee and Pillay, 2016). Therefore, the oxidized and reduced forms of Tpx and BCP were 
examined and it was found a higher hydrogen peroxide concentration was required to distribute 
Tpx and BCP into their oxidized forms for the bi-fan motif (Figure 2.10 B, black arrow). The 
result suggested that the bi-fan motif offered a greater hydrogen peroxide reduction capacity 
when compared to the bi-parallel motif which may be significant for redox defence systems in 







Figure 2.10. Core model simulations of the bi-parallel (A) and bi-fan (B) motif designs show 
that the bi-fan connectivities allow for the system to handle higher hydrogen peroxide 
concentrations. The thioredoxin reductase flux ( ___ ) and the steady-state concentrations of 
the reduced ( +++++ ) and oxidized ( ___ ) forms of Tpx and the reduced ( ___ ) and oxidized 
( +++++ ) forms of BCP are shown. The black arrow in each of the figures indicates the crossing 
point of the reduced and oxidized peroxiredoxin species concentrations, where oxidized species 
begin to accumulate in the system. 
Another critical factor in the activity of the systems lay in their dependence on reduced 
thioredoxin concentrations. A low thioredoxin concentration could result from a high 
thioredoxin demand for other reductive reactions as explained earlier in this thesis (Chapter 1, 
section 3.2). The effect of a changing thioredoxin demand for both TrxB and TrxC sub-systems 
was evaluated (Figure 2.11). With regard to the bi-parallel motif, the peroxiredoxins’ flux 
remained constant if their cognate thioredoxin concentration was not varied, i.e. when the 
concentration of the thioredoxin C pool (TrxCSH) was varied, Tpxs’ flux remained constant 
and vice versa. However, both peroxiredoxins were sensitive to changes in the demand of their 
cognate thioredoxin concentration (Figure 2.11 A-B). This result supported the analytical 
solution of the system (section 2.3.3) which showed that a thioredoxin in one arm of the motif 
had no effect on the opposite arms’ peroxiredoxin flux provided that NADPH and thioredoxin 






Figure 2.11. Steady-state flux analysis of the bi-parallel (A-B) and bi-fan (C-D) systems 
showing the effect of increasing the respective total thioredoxin B and C moiety pools on 
peroxiredoxin mediated hydrogen peroxide reduction fluxes in these systems. Fluxes of the 
reactions pertaining to hydrogen peroxide reduction for the peroxiredoxins Tpx ( ___ ) and 
BCP ( ++++ ) are shown for both the bi-fan and bi-parallel motif models as the availability of 
reduced thioredoxin B and C increases.  
In contrast to the bi-parallel motif, the rates of hydrogen peroxide reduction by Tpx and 
BCP were consistent regardless of changes in either thioredoxin concentration 
(Figure 2.11 C-D). Interestingly, this result shows that this systems’ configuration allows for 
the activity of both peroxiredoxins when a single thioredoxin is inactive, partially active or 
present at low concentrations within the system. The fluxes of both Tpx and BCP mediated 






To determine whether changes in the reduced thioredoxin B and C moiety concentrations 
also resulted in different behaviors by the bi-parallel and bi-fan systems, two additional 
reactions (PSS + TrxBSH  PSH + TrxBSS and PSS + TrxCSH  PSH + TrxCSS, where 
PSS and PSH represent oxidized and reduced proteins respectively) were added to both motif 
reaction schemes to simulate the increased demand for thioredoxins within these systems 
(Figure 2.12).  
 
Figure 2.12. Steady-state flux analysis of the bi-parallel (A-B) and bi-fan (C-D) systems 
showing the effects of keeping constant thioredoxin B and C moiety pools respectively and the 
impact on the fluxes of peroxiredoxin mediated hydrogen peroxide reduction when thioredoxin 
B and C demands increase respectively. Fluxes of the Tpx ( ___ ) and BCP ( ++++ ) mediated 
reduction of hydrogen peroxide are shown as the rate of thioredoxin B and C consumption is 
increased. Note: the y-axis scales vary between the bi-parallel and bi-fan motif designs due to 





When using constant thioredoxin B and C moiety pools respectively, increasing the rate 
of thioredoxin consumption by PSS meant less thioredoxin was available to reduce the 
peroxiredoxins, Tpx and BCP. Thus, there was a decrease in fluxes associated with hydrogen 
peroxide reduction when their cognate steady-state reduced thioredoxin concentrations were 
reduced (Figure 2.12). In agreement with Figure 2.11, the bi-parallel motif design 
(Figure 2.12 A-B) showed that when thioredoxin B was depleted (Figure 2.12 A), the 
Tpx-mediated hydrogen peroxide reduction flux decreased while BCP’s reductive flux 
remained unaffected and vice versa (Figure 2.12 B). On the other hand, for the bi-fan motif 
(Figure 2.12 C-D), when either reduced thioredoxin concentration was decreased then both the 
fluxes of Tpx and BCP mediated hydrogen peroxide reduction decreased but the system did 
display a greater tolerance towards reductant concentration fluctuations. For example, the Tpx 
and BCP hydrogen peroxide reduction fluxes decreased from 0.59 µM.s-1 to 0.41 µM.s-1 in the 
bi-fan motif (Figure 2.12 C-D) whereas in the bi-parallel motif, peroxiredoxin reductive fluxes 
decreased from 0.46 µM.s-1 to 0.15 µM.s-1 over the same range (Figure 2.12 A-B). This result 
supports the hypothesis that reductive redundancy could contribute towards M. tuberculosis 
persistent latency within the host.  
2.4 Discussion 
Protein-protein interaction maps provide an insightful and valuable framework for 
understanding the functional organization of a cells’ proteome (Stelzl et al., 2005). Here the 
redox defence networks of M. tuberculosis, E. coli and S. cerevisiae were analyzed with focus 
on the redox couples crucial in hydrogen peroxide defence. This analysis was carried out with 
the aim of identifying key motifs which support Mtb cell viability within host granuloma during 
the course of infection (Pieters, 2008).  
Motifs containing three nodes were present across all three organisms, suggesting 
conservation of these connection designs within redox defence networks. However, analysis of 
four node motifs showed differences between the systems’ connections. Among the 14 motifs 
detected across all three redox networks (Table 2.2), M. tuberculosis had two unique 
configurations. One motif, ID: 2118/PMYH9, was found to be the connection of the 
peroxiredoxin AhpE with the MSH/Mrx-1 system, with the subsequent reduction of hydrogen 
peroxide by AhpE (Figure 2.4 A). The presence of such a motif in M. tuberculosis was 
attributed to the presence of the MSH/Mrx-1 system, which is absent in the E. coli and 





comprised of two thioredoxins, TrxB and TrxC, both reducing the two peroxiredoxins Tpx and 
BCP (Figure 2.4 A; Figure 2.9 A).  
The bi-fan and control bi-parallel motif designs were compared using analytical solutions 
which revealed that the peroxiredoxin arms of the bi-parallel system were independent of one 
another. In contrast, the bi-fan motif showed dependence on both thioredoxins within the 
system and was further examined by analysis of ordinary differential equations, but these 
solutions were extremely complex (equation S1, Appendix) and core kinetic models were then 
opted for use in further analysis. It is also important to note that reaction and affinity constants 
within the reaction schemes outlined in this chapter were set to one for an easier interpretation 
of the behaviour of the system. With realistic values, the fluxes of these reactions are expected 
to change but the overall trends outlined by the two motif designs are still expected (described 
in Chapter 2, equations 11, 25 and 26). 
Core kinetic models revealed important system properties when comparing the bi-parallel 
and bi-fan motif designs. The bi-fan motif design required a higher concentration of hydrogen 
peroxide before the peroxiredoxins’ redox cycles became saturated (Figure 2.10) and the 
peroxiredoxin-mediated hydrogen peroxide reduction fluxes were relatively robust to a change 
in either thioredoxin concentration, showing that the reduction redundancy within the system 
may be beneficial to the cell. Thus, if a single thioredoxin is inactive or at low concentrations, 
both peroxiredoxins can still be able to substantially reduce hydrogen peroxide. By contrast, in 
the bi-parallel motif the hydrogen peroxide reduction system is reliant on both thioredoxins to 
be present at significant concentrations for their cognate peroxiredoxins to remain active 
(Figure 2.11). This result was further bolstered by carrying out simulations of the bi-fan and 
bi-parallel motif designs using a biologically realistic environment where the total pool of 
thioredoxin in the cell was kept constant and the thioredoxin B and C fluxes were split amongst 
the peroxiredoxin and other thioredoxin demands (Figure 2.12). The results show that in the 
bi-fan motif, both Tpx and BCP maintained their hydrogen peroxide reductive capabilities and 
remained more robust to thioredoxin concentration fluctuations when compared to that of the 
bi-parallel motif design (Figure 2.12 A-B).  
Figure 2.12 shows the effects of keeping thioredoxin B and C moiety pools constant and 
the subsequent effects on the peroxiredoxin fluxes. When the thioredoxin oxidation rates were 
increased in the bi-parallel motif, the flux of hydrogen peroxide reduction for each of the 





peroxiredoxin flux remained constant at 0.40 µM.s-1 (Figure 2.12 A-B). In contrast, when either 
of the thioredoxin oxidation rates where increased in the bi-fan motif, both peroxiredoxin 
fluxes decreased simultaneously from 0.59 µM.s-1 to 0.43 µM.s-1 (Figure 2.12 C-D). When 
compared to the bi-parallel motif design, this result still shows that the redundancy within the 
bi-fan motif allows the hydrogen peroxide reductive capacity of the cell to be maintained in 
the face of increasing thioredoxin oxidation. The redundancy of the thioredoxin-mediated 
reduction of peroxiredoxins in the bi-fan motif shows that this system may have evolved to 
ensure sustainable reduction of peroxiredoxins when thioredoxin concentrations fluctuate 
within the cell. This is supported by the fact that thioredoxin is known to be involved in various 
other cellular reactions including DNA replication, transcription factor regulation and a growth 
factor among many other roles (Powis et al., 2000). Thioredoxin also plays a role in helping 
cells recover from oxidative damage via methionine sulfoxide reductase (MsrA) (Gleason and 
Holmgren, 1988; Gladyshev, 2002) and could also be redistributed in this manner to aid in cell 
survival during hypoxic conditions. A study carried out where auranofin, an anti-rheumatic 
drug, was repurposed to be used as a potent thioredoxin reductase inhibitor in an Mtb study 
(Harbut et al., 2015) could further support the importance of the bi-fan motif embedded within 
the redox defence network. By inhibiting thioredoxin reductase, the bi-fan motif as well as 
other thioredoxin-dependent reactions would be essentially halted. The results shown in this 
chapter also serve as a rationale for the effectiveness of auranofin, ideally making the bi-fan 
motif and other central hub systems suitable candidates for future drug targets focusing on 
redox protein inhibition within the Mtb and other pathogenic cells sharing similar properties. 
To our knowledge results presented here are the first such analysis for the hydrogen 
peroxide reduction network of M. tuberculosis. These findings needed to be confirmed using 
realistic parameters and consequently the components of the bi-fan motif were prime 










Chapter 3: In vitro analysis of the thioredoxin reductase, thioredoxin C and 
the bacterioferritin comigratory protein components within the bi-fan 
motif 
3.1 Introduction 
In Chapter 2, structural analysis of the M. tuberculosis redox defence network revealed 
a novel bi-fan motif associated with hydrogen peroxide defence, which comprised the two 
biologically active thioredoxins (TrxB and TrxC) both reducing the two peroxiredoxins Tpx 
and BCP. The work presented in this chapter serves as a basis to show that the bi-fan motif 
could be assessed using in vitro analysis. As a first step it was necessary to obtain pure protein 
samples of the Mtb thioredoxin reductase, thioredoxin C and BCP proteins for the kinetic 
characterization of the interactions between these proteins. 
3.2 Materials  
The GeneJET Plasmid Miniprep Kit was obtained from ThermoFisher Scientific 
(Johannesburg, South Africa) and the TGX Stain-Free™ FastCast™ Acrylamide Kit (12%) 
was obtained from BIO RAD Laboratories (Pty) Ltd (Johannesburg, South Africa). 
Dithiothreitol (DTT), bovine pancreas insulin, 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB), 
bovine serum albumin (BSA), isopropyl β-D-1-thiogalactopyranoside (IPTG), 
kanamycin antibiotic, β-nicotinamide adenine dinucleotide phosphate (NADPH), 
4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF), phenylmethane sulfonyl 
fluoride (PMSF), Coomassie G-250 and R-250 and N,N,Nʹ,Nʹ-tetramethylethylenediamine 
(TEMED) were obtained from Sigma (Capital Labs, South Africa). Ni-NTA agarose was 
obtained from Whitehead Scientific (Pty) Ltd (Cape Town, South Africa). Common reagents 
and chemicals were obtained from Saarchem (Merck, South Africa). E. coli BL21 cells were 
available in the lab. Gene synthesis of the thioredoxin reductase (TR, rv3913), thioredoxin C 
(TrxC, rv3914) and bacterioferritin comigratory protein (BCP, rv2521) clones in pET28a 
expression vectors was carried out by GenScript Ltd (Hong Kong). The DNA sequences were 
codon optimized for successful expression in E. coli BL21 host cells. 
3.2.1 Preparation of lyophilized plasmid DNA 
The lyophilized pET28a clone plasmid DNA was resuspended in 1× TE buffer by gentle 
finger tapping as per the protocol provided by GenScript. These DNA stock solutions were 






3.2.2 Preparation of common reagents 
3.2.2.1 Kanamycin stock solution 
A stock solution (30 mg/mL) was prepared by dissolving kanamycin sulfate (0.3 g) in 
10 mL of dH2O. The solution was filter sterilized (0.2 µm filter) and stored in 1 mL aliquots at 
-20˚C.  
3.2.2.2 IPTG stock solution 
A stock solution (100 mM) was prepared by dissolving IPTG (0.238 g) in 10 mL of dH2O. 
The solution was filter sterilized (0.2 µm filter) and stored in 1 mL aliquots at -20˚C. 
3.2.2.3 DTT stock solution 
A DTT stock solution (1 M) was made fresh daily. DTT powder (0.154 g) was dissolved 
in 1 mL of dH2O and stored at room temperature. 100 µL of this stock was made up to a final 
volume of 1 mL (final concentration 100 mM) for use in the thioredoxin specific activity assay. 
3.2.2.4 Bovine pancreas insulin stock solution 
A stock insulin solution (1.6 mM) was prepared by suspending bovine pancreas insulin 
(50 mg) in 500 µL 100 mM potassium phosphate buffer (pH 6.5). The pH of the solution was 
thereafter adjusted to 2-3 with 1 M HCl to completely dissolve the protein and was thereafter 
rapidly titrated back to the original pH 6.5 and made up to a final volume of 5 mL with ddH2O. 
The clear solution was stored at -20˚C until use in the thioredoxin specific activity assay. 
3.2.2.5 DTNB stock solution 
A stock solution of DTNB (63.1 mM) was freshly prepared by dissolving DTNB powder 
(0.025 g) in 99% ethanol to a final volume of 1 mL. The resulting solution is light sensitive 
and was subsequently stored in the dark for use in the thioredoxin reductase specific activity 
assay. 
3.2.2.6 NADPH stock solution 
NADPH (stock solution and powder) is susceptible to oxidation by exposure to air. To 
avoid constant exposure to air, stock vials were prepared by keeping 10 mg portions of the 
powder in separate micro centrifuge tubes (-20˚C, caps were further sealed with parafilm for 
longer periods of storage). At the time of use, the sub-aliquoted stock was resuspended in 





concentration was determined by direct spectroscopy at 340 nm using an extinction coefficient 
of 6200 M-1.cm-1 (Arnér and Holmgren, 2000a). 
3.2.2.7 10% (w/v) ammonium persulfate solution 
A 10% (w/v) ammonium persulfate solution for use in the SDS-PAGE electrophoresis 
technique was prepared fresh at time of use by dissolving ammonium persulfate powder (0.2 g) 
in 2 mL of dH2O.  
3.2.2.8 SDS-PAGE sample loading buffer (4×) 
The SDS-PAGE sample loading buffer was prepared by mixing 1 M Tris-HCl 
(pH 6.8, 1.5 mL), 1 M DTT (3 mL), SDS (0.6 g), bromophenol blue (0.03 g), glycerol (2.4 mL) 
and bringing up to a final volume of 7.5 mL. The solution was aliquoted and stored at 4˚C.  
3.2.2.9 SDS-PAGE tank buffer (10×) 
10× SDS-PAGE tank buffer was prepared by adding Tris (15.15 g), glycine (71.32 g) 
and SDS (5 g) to dH2O and brought up to a final volume of 500 mL. For SDS-PAGE 
electrophoresis, 100 mL (10X SDS-PAGE tank buffer) was brought up to a final volume of 
1 L using dH2O.  
3.2.2.10 Bovine serum albumin standard solution 
A 1 mg/mL of bovine serum albumin solution was made up in dH2O for further use in 
the Bradford protein concentration quantitation assay. 
3.2.2.11 Bradford reagent  
Coomassie brilliant blue G-250 (50 mg) was dissolved in methanol (50 mL). Thereafter, 
85% (w/v) phosphoric acid (100 mL) was added to the solution and the made up to a total 
volume of 1 L using dH2O. The solution was stirred for one hour and filtered through Whatman 
number 1 filter paper into a darkened amber bottle and stored at 4˚C.  
3.2.3 Bacterial growth media  
3.2.3.1 Luria Bertani (LB) broth 
Tryptone powder (1% (w/v)), yeast extract (0.5% (w/v)) and NaCl (0.5% (w/v)) were 
dissolved in dH2O while making up to the required volume of broth. The broth was then 
autoclaved, stored at room temperature and supplemented with the appropriate antibiotic when 





3.2.3.2 Luria Bertani (LB) agar  
Tryptone powder (1% (w/v)), yeast extract (0.5% (w/v)), NaCl (1% (w/v)) and 
bacteriological agar (2% (w/v)) were dissolved in dH2O and made up to the required volume. 
The solution was autoclaved and upon cooling, the solution was poured into petri dishes. The 
broth was also supplemented with the appropriate antibiotic when necessary (kanamycin, 
50 µg/mL final concentration). The solidified petri plates were stored at 4˚C when not in use.  
3.2.3.3 Glucose stock solutions 
 A glucose stock solution (1 M) was prepared by dissolving glucose powder (1.8 g) in 
10 mL of ddH2O. The solution was filter sterilized (0.2 µm filter) and the solution stored at 4˚C 
until use. A working glucose solution (10% (w/v)) was prepared by dissolving glucose powder 
(1 g) in 10 mL of ddH2O. The solution was filter sterilized (0.2 µm filter) and stored at 4˚C 
until use. 
3.2.3.4 SOC media recipe 
Tryptone powder (2% (w/v)), yeast extract (0.5% (w/v)), NaCl (10 mM), KCl (2.5 mM) 
and MgCl2 (10 mM) were dissolved in dH2O and made up to the required volume. The resulting 
solution was autoclaved and upon cooling was supplemented with glucose (20 mM final 
concentration). SOC media was stored at 4˚C when not in use.  
3.3 Methods 
3.3.1 Transformation of pET28a plasmids into E. coli BL21 cells for expression 
E. coli BL21 cells were made competent using the calcium chloride (CaCl2) treatment 
method (Dagert and Ehrlich, 1979). An overnight E. coli BL21 culture (1 mL) was transferred 
into fresh LB broth (25 mL) and grown until an OD600 of 0.3-0.4 was obtained (150 rpm, 37˚C). 
Duplicate 10 mL samples were placed in ice-cold centrifuge tubes, chilled on ice (10 minutes) 
and thereafter centrifuged (4500 x g, 10 minutes, 4˚C). The supernatant was discarded and the 
resulting cell pellet resuspended in ice-cold 0.1 M CaCl2 (10 mL per pellet). The solution was 
then centrifuged once more (4500 x g, 10 minutes, 4˚C), the supernatant discarded and the 
pellet resuspended in ice-cold 0.1 M CaCl2 (2 mL per cell pellet). The suspension was 
incubated on ice for a further 30 minutes before transformation. 
Stock solutions of pET28a clones were made up to 0.04 µg/µL. Competent cells (20 µL) 





ice (4˚C, 30 minutes). The mixture was then heat shocked (42˚C, 90 seconds) and immediately 
cooled on ice (4˚C, 2 minutes). Pre-warmed SOC media (80 µL, 37˚C) was added to the 
competent cells transformation mix and incubated at 37˚C in a shaking water bath (1 hour). 
The transformation mix (50 µL) was spread plated on LB agar plates containing kanamycin 
(final concentration, 50 µg/mL) and grown overnight at 37˚C.  
Control LB agar plates were set up to check viability of E. coli BL21 cells (no kanamycin 
added, only competent cells plated) and test activity of kanamycin antibiotic (final 
concentration, 50 µg/mL, plated competent cells without plasmid). Controls were carried out 
for each of the three plasmid transformations and a single colony selected from successfully 
transformed plates and grown in LB broth containing kanamycin (final concentration, 
50 µg/mL) overnight at 37˚C. The GeneJET Plasmid Miniprep Kit was then used to isolate 
plasmid DNA from the three respective overnight cultures. 
3.3.2 Sequencing of gene synthesis products  
Expression plasmids containing the rv3913, rv3914 and rv2521 genes respectively, were 
sequenced in both directions using the pET28a plasmid T7 promoter and terminator primers 
(Central Analytical Facility, Stellenbosch University, South Africa). Sequences were curated 
manually using the BioEdit Sequence Alignment Editor version 7.2.5 (Hall, 1999) and 
converted to amino sequences using the online ExPASy translate tool 
(http://web.expasy.org/translate). The amino acid sequences were then aligned to the 
corresponding sequences from the Tuberculosis Database (TBDB, http://www.tbdb.org) using 
the online Clustal Omega sequence alignment tool (http://www.ebi.ac.uk/Tools/msa/clustalo).  
3.3.3 SDS-PAGE acrylamide gel electrophoresis 
Protein samples were visualized on a 12% acrylamide gel during SDS-PAGE run using 
the BIO RAD Mini-PROTEAN Tetra cell electrophoresis equipment (1.0 mm glass plates 
used). Stacker and resolver gels were prepared as per protocol provided with the TGX 
Stain-Free™ FastCast™ Acrylamide Kit (12%) and polymerization of the gel initiated with the 
addition of TEMED and 10% (w/v) ammonium persulfate. Samples were prepared by boiling 
them (5 minutes, 80-90˚C) in 4× SDS-PAGE sample loading buffer before loading them onto 
the gels. 
Gels were run for a total of 90 min (100V) and thereafter stained in Coomassie blue gel 





acid (10% (v/v))) while on an orbital shaker (50 rpm) overnight. The following day, excess 
stain was removed and the gels de-stained with de-stain solution I (50% (v/v) methanol and 
10% (v/v) glacial acetic acid) until the gel background became clear and was finally placed in 
de-stain II (5% (v/v) methanol and 7% (v/v) glacial acetic acid) until the gel returned to its 
original size. Gels were then photographed under white light using the DNR MiniBIS Pro 
Versadoc imaging system.   
3.3.4 IPTG expression of the rv3913, rv3914 and rv2521 genes from M. tuberculosis in host 
E. coli BL21 cells 
A high cell density culturing method (Sivashanmugam et al., 2009) was used for the high 
yield expression of recombinant proteins in E. coli BL21 cells transformed with the pET28a 
expression vectors housing the Mtb TR, TrxC and BCP genes respectively. The transformed 
cells were cultured in three separate LB broth cultures containing kanamycin (final 
concentration, 50 µg/mL) overnight to obtain high cell density cultures (150 rpm, overnight, 
37˚C). Cells were then centrifuged (1500 x g, 5 minutes) and the pellet resuspended in high 
cell density media (LB broth, 50 mM Na2HPO4, 25mM KH2PO4, 5mM MgSO4, 0.2 mM CaCl2, 
0.1% (w/v) NH4Cl, 1% (v/v) of 10% (w/v) glucose, pH 8) and grown for 1 hour (37˚C, 
150 rpm) before the addition of IPTG (0.5 mM) to begin induction of the recombinant proteins 
(37˚C, 150 rpm). Hourly samples were taken following IPTG induction to determine the 
optimal time for each proteins’ induction and the samples centrifuged (12 000 x g, 10 minutes, 
4˚C) and pellets stored at -20˚C.  
3.3.5 Nickel affinity protein (Ni-NTA) purification 
 Cell pellets (after IPTG induced expression) were resuspended in refrigerated 1× 
phosphate-buffered saline (PBS) (500 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, 20% (v/v) glycerol, 0.2 mM AEBSF, 1 mM PMSF (added to sonication tube 
separately as it is unstable in water), pH 7.2) equal to ten times the weight of cells and sonicated 
using the VirSonic 60 Ultrasonic Cell Disrupter (8W) for ten seconds followed by ten seconds 
on ice. This sonication procedure was repeated ten times for each sample. The cell suspension 
was thereafter centrifuged (12 000 x g, 30 minutes, 4˚C) and the supernatant stored at -20˚C 
for further use in the Ni-NTA purification columns. 
Protein purification columns (total volume of 15 mL) were packed with Ni-NTA agarose 
beads (2 mL) and the ethanol from the Ni-NTA agarose allowed to flow through the column, 





volume of equilibration buffer (20 mM imidazole, 0.5 M NaCl, 1mM β-mercaptoethanol, 
20 mM Tris-HCl (pH 8)) and thereafter incubated with the appropriate crude extract (2 hours, 
4˚C) in a Revolver™ 360˚ Sample Mixer. Following incubation, the unbound fraction was 
eluted by gravity and the column washed twice with one column volume of 1× PBS buffer 
(500 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 20% (v/v) glycerol, pH 7.2) 
to remove unbound and loosely bound proteins from the column. The column was thereafter 
washed with one column volume each of 1× PBS buffer containing a gradient of imidazole 
concentrations (500 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 20% (v/v) 
glycerol, imidazole at 20, 40, 80, 150 and 250 mM respectively, pH 7.2) and samples collected 
and analyzed using SDS-PAGE (Section 3.3.3). The resin was then incubated with 
0.5 M NaOH (30 minutes, room temperature), eluted by gravity and stored in 30% (v/v) ethanol 
(4˚C).  
3.3.6 Specific activity assays of the Mtb thioredoxin reductase and thioredoxin C proteins 
Crude protein samples were collected every hour following IPTG induction and the total 
protein concentration determined using the Bradford assay. This assay is based on the binding 
of Coomassie brilliant blue G-250 to protein residues, shifting the dye from the cationic form 
to the anionic form causing a shift in the maximum absorption from 365 nm to 595 nm 
(Bradford, 1976). A standard curve of varying concentrations of bovine serum albumin 
(0 - 100 µg/mL) against the absorbance value at 595 nm was constructed. Measurements were 
all taken from the linear region of the standard curve (Appendix, Figure S1). 
The DTNB reduction assay (Holmgren, 1977) was used to determine the activity of the 
Mtb thioredoxin reductase protein. The final assay contained 0.1 M Tris-HCl (pH 8), 0.5 mM 
DTNB, 0.24 mM NADPH, 0.1 mg/mL BSA, 0.5 M NaCl and crude extract containing 
thioredoxin reductase or pure protein in a final volume of 1 mL. NaCl (0.5 M) was included in 
the reaction mixture as the presence of a univalent cation allowed increased sensitivity of the 
reaction (Lim and Lim, 1995). The reaction was initiated with the addition of the protein sample 
and proceeded at 25˚C. The change in absorbance at 412 nm was directly monitored and a 
cuvette without thioredoxin reductase was used as a reference. All absorbance measurements 
were carried out using the UV-1800 Shimadzu spectrophotometer.  
For thioredoxin C, the insulin reduction assay was used to determine the activity of the 
protein (Holmgren, 1979). To fully reduce thioredoxin C before beginning the reaction, a 





protein (final concentration, 0.05 µg/mL) with 0.1 M DTT (10 µL) for 10 minutes (25˚C) was 
used in this study (Padayachee and Pillay, 2016). A master mix solution containing 84 mM 
potassium phosphate buffer (pH 7), 2.67 mM EDTA and 0.21 mM insulin was made to a final 
volume of 9 mL. The master mix (750 µL) was placed in a 1 mL cuvette and the pre-reduced 
protein suspension (250 µL) was added to the cuvette to initiate the reaction. The final reaction 
mixture contained 63 mM potassium phosphate buffer (pH 7), 2 mM EDTA, 0.01 mM insulin 
and 1 mM DTT in a final volume of 1 mL. Absorbance values were directly monitored at 650 
nm in the UV-1800 Shimadzu spectrophotometer and a cuvette with no protein was used as the 
reference cuvette. 
3.4 Results 
3.4.1 Successful gene synthesis and protein expression of the rv3913, rv3914 and rv2521 
genes from M. tuberculosis  
Gene synthesis was used in this study as the genomic DNA of M. tuberculosis was 
difficult to obtain due to the health risk involved with the culturing of the bacterium outside of 
a designated lab. Sequence information was readily available from the Tuberculosis Database 
(TBDB, http://www.tbdb.org) and the genes were synthesized in the pET28a expression 
plasmid. Codon optimization was also selected as M. tuberculosis and E. coli utilize and favor 
different codons for translation (Lin et al., 2002) 
Once the expression plasmids housing the synthesized genes were sequenced and 
translated to amino acid sequences, they were aligned to the amino acid sequences of their 
respective proteins. The alignment showed that the three proteins were identical to the original 






Figure 3.1. Amino acid sequence alignments of the transcripts of the Mtb thioredoxin reductase 
(A), thioredoxin C (B) and BCP (C) genes housed in the pET28a expression plasmids reveal 
complete identity when compared to the transcripts of the rv3913, rv3914 and rv2521 genes 
from the Tuberculosis Database (TBDB) respectively.  
Following sequence confirmation, E. coli BL21 cells transformed with the respective 
plasmids were induced with IPTG to express the proteins to determine whether they would 
successfully express under the conditions described, be degraded or stored in inclusion bodies 
(Thomas and Baney, 1996). Samples were taken hourly following IPTG induction to determine 
the optimal time points for expression for each of the three respective proteins using 
SDS-PAGE. Mtb thioredoxin reductase, thioredoxin C and BCP all ran at their expected sizes 
(35, 13 and 19 kDa respectively) indicating that the proteins were successfully expressed 
(Figure 3.2). The optimal induction time points for the expression of TR, TrxC and BCP were 






Figure 3.2. E. coli BL21 cells housing the three pET28a expression plasmids for the proteins 
thioredoxin reductase (A), thioredoxin C (B) and BCP (C) were induced with 0.5 mM IPTG 
under the control of the T7 promoter. Samples were taken every hour following induction 
(1-6 hrs. and an overnight sample, O/N) and run against an uninduced sample (U/I) and a 
BioRad precision plus unstained protein standard (MWM, 10-250 kDa range).  
3.4.2 Successful purification of the thioredoxin reductase, thioredoxin C and BCP 
proteins using the Ni-NTA purification method and testing of their specific activities 
To purify recombinant protein, transformed E. coli BL21 cells containing the expression 
plasmids were induced with IPTG (Section 3.3.4) and grown for the optimal times based on 
their respective expression profiles (Figure 3.2). The crude extracts were used in nickel affinity 
chromatography (Ni-NTA) purification and a modified wash step including 20% (v/v) glycerol 





purification of His-tagged recombinant protein from a crude extract starting sample. Glycerol 
(20% (v/v)) was added to prevent non-specific hydrophobic protein interactions which had 
resulted in co-purification of contaminating protein products (data not shown, Bornhorst and 
Falke, 2000). The sizes of protein products purified corresponded to the expected sizes for TR, 
TrxC and BCP respectively.  
 
Figure 3.3. Nickel affinity chromatography (Ni-NTA) purification of the His-tagged 
thioredoxin reductase (A), thioredoxin C (B) and BCP (C) proteins to yield pure protein 
samples. Due to low expression of thioredoxin C, the cell debris pellet following sonication 
was run alongside pure protein (B) to determine if sonication was successfully releasing 
thioredoxin C. The samples were eluted over a range of imidazole concentrations (20-250 mM) 
and run against the PageRuler Unstained Protein ladder (MWM, 10-200 kDa range).  
Problems were encountered when up-scaling the expression experiment for the 





It was assumed that insufficient sonication was performed and therefore the pellet was 
compared to the eluate (Figure 3.3 B) to determine if this was the case. Based on the gel image 
protein expression was much lower overall but when samples were pooled a sufficient amount 
of protein was obtained to carry out the insulin reduction assay (Section 3.3.6).  
Once protein expression was optimized for the three proteins, specific activities of the 
Mtb thioredoxin reductase and thioredoxin C proteins were determined using the DTNB and 
insulin reduction assays respectively (Figure 3.4) across a number of time points (1-6 hours, 
overnight and pure protein samples). Pure protein was also tested to determine if the protein 
fractions purified by Ni-NTA chromatography maintained activity. The specific activities of 
the proteins corresponded to the SDS-PAGE data (Figure 3.2) and the pure proteins were active 
(Figure 3.4). 
 
Figure 3.4. Specific activities of the thioredoxin reductase DTNB reduction assay (A) and 
thioredoxin C insulin reduction assay (B) of crude and pure protein fractions induced with 0.5 
mM IPTG from one hour until a final overnight (O/N) sample was taken. Duplicate samples 






To study the M. tuberculosis thioredoxin reductase/thioredoxin C/BCP coupled system, 
NADPH oxidation can be monitored at 340 nm but pure protein samples were required. In this 
study three pET28a expression plasmids containing the genes for Mtb thioredoxin reductase, 
thioredoxin C and BCP respectively were acquired. Sequencing and alignment of translated 
amino acid sequences of the respective expression plasmids (Figure 3.1) revealed that the three 
genes were correctly synthesized and were under the control of the T7 promoter of the pET28a 
expression plasmid. The clones were IPTG induced (Figure 3.2) and Ni-NTA chromatography 
purification resulted in successful purification of the proteins in this study (Figure 3.3).  
To test if the pure proteins samples could be used for future kinetic work, specific activity 
assays were used that were previously developed and optimized in our lab for the thioredoxin 
reductase and thioredoxin proteins. The thioredoxin assay based on the DTT-dependent 
reduction of insulin (Holmgren, 1979) was chosen. The assay involved pre-incubating 
thioredoxin C containing crude extract with DTT prior to the test reaction, which shortened the 
overall reaction time and removed the need for pure thioredoxin reductase protein when 
compared to previous assays (Padayachee and Pillay, 2016). The thioredoxin reductase specific 
activity assay involved the reduction of DTNB and directly monitoring absorbance at 412 nm 
(Arnér and Holmgren, 2000a) as opposed to the use of the thioredoxin protein, the natural 
substrate of thioredoxin reductase. Divalent cations were also included in the reaction 
(0.5 M NaCl) as they were found to greatly increase the sensitivity of the DTNB reduction 
assay by altering the thioredoxin reductase conformation resulting in an exposed active site 
which could readily react with DTNB (Lim and Lim, 1995).  
The specific activity assays described above were used in conjunction with the expression 
profile (Figure 3.2 and 3.4 respectively) to determine the optimal time points for expression. It 
was concluded that overnight expression for thioredoxin reductase and 6 hours of expression 
for thioredoxin C yielded the highest specific activities. The hydrogen peroxide reduction 
activity of the BCP protein could also be measured using the horseradish peroxidase (HRP) 
competition assay (Nelson and Parsonage, 2011; Toledo et al., 2011). The assay takes 
advantage of the high reaction rate of HRP with hydrogen peroxide and its oxidation to 
compound I can be directly measured at an absorbance of 403 nm. The competition between 
the HRP and peroxiredoxin for hydrogen peroxide can therefore give an accurate second-order 





However, due to time constraints, this assay was not carried out but future studies will involve 
using the HRP competition assay to determine the reactivity of BCP with hydrogen peroxide 
followed by an analysis of the entire bi-fan motif. The purified system will therefore serve as 
a comprehensive and experimentally tractable in vitro tool for studying the hydrogen peroxide 

























Chapter 4: General discussion  
 
M. tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a significant health 
concern claiming millions of lives per annum and with the rise in drug resistant strains, 
treatment regimens have become that much more complex. Able to evade the host immune 
system, M. tuberculosis can remain dormant and reactivate even after decades within the host. 
The strong defence exhibited by the M. tuberculosis bacterium along with the inability to curb 
infection using established treatment options has warranted the exploration of new avenues in 
search of alternative TB vaccines, drug therapies and intracellular druggable targets. Systems 
biology is one such avenue which takes into account the interacting nature of cellular 
components and the subsequent consequences of these interactions. Research presented in this 
dissertation was centered on using systems biology approaches to potentially elucidate new 
inhibitory targets within the redox defence network of M. tuberculosis by using mathematical 
and computational modeling techniques and in vitro analyses. A further aim was to create a 
broad yet comprehensive understanding of the interactions between the redox defence proteins 
partially responsible for the viability of M. tuberculosis in the host for decades despite the 
constant bactericidal microenvironment it inhabits during the course of infection.  
The complete detailed reconstruction of the Mtb redox defence network has not, to our 
knowledge, been previously presented in literature and this step allowed the development of 
wire diagrams that mapped out the interactions of the hydrogen peroxide reduction network. 
Using the canonical E. coli and S. cerevisiae redox defence networks as comparison, the 
hydrogen peroxide reduction network of M. tuberculosis was analyzed using motif detection 
programs to detect both common and unique motifs. A unique bi-fan motif was uncovered 
within the M. tuberculosis redox defence network and the properties of this motif design were 
further explored using mathematical as well as core computational modeling to simulate 
steady-state behavior of the bi-fan motif.  
Both the analytical solutions and core computational modeling showed that the reductive 
redundancy found within the bi-fan system makes it particularly robust to changes in either 
thioredoxin concentration with the rates of hydrogen peroxide reduction mediated by Tpx and 
BCP being unaffected when either thioredoxin concentration was varied. Computational 
modeling of the bi-fan system further showed that the bi-fan motif design required a higher 





Tpx and BCP redox cycles. Considering the granuloma microenvironment in which 
M. tuberculosis resides over the course of infection, the presence of the bi-fan motif embedded 
in the redox defence network could be important for the cells’ survival by allowing their 
hydrogen peroxide reductive capacity to remain robust to changes in thioredoxin demand 
throughout the cell and to tolerate higher oxidative stress. Analysis of the bi-fan and bi-parallel 
systems in a biologically realistic environment where the thioredoxin B and C concentrations 
are expected to fluctuate in the cell based on the varying thioredoxin demand, showed that the 
bi-fan motif displayed greater robustness with regard to the availability of thioredoxin when 
compared to the bi-parallel motif. Intriguingly, thioredoxin reductase is crucial for maintaining 
the thioredoxin redox poise in this motif and its inhibition via auranofin dramatically affects 
cell viability (Harbut et al., 2015). The thioredoxin reductase inhibition study exemplifies the 
possible importance of the bi-fan motif within the M. tuberculosis redox defence network and 
its role in M. tuberculosis’ persistence once within the host. The description of this motif is the 
first such analysis regarding the complete hydrogen peroxide reduction network of 
M. tuberculosis. Moreover, this method could also be applied to other pathogenic bacteria and 
help in future characterization studies of various cellular networks. Due to a lack of kinetic 
information regarding the proteins comprising the bi-fan motif, the components were 
consequently selected for in vitro kinetic analysis. 
The genes for thioredoxin reductase (rv3913), thioredoxin C (rv3914) and BCP (rv2521) 
were synthesized on pET28a expression plasmids under the control of the T7 promoter.  
Expression of the genes were IPTG-induced and crude samples containing the three respective 
proteins were Ni-NTA purified to obtain pure protein samples. The thioredoxin reductase and 
thioredoxin C proteins were then assayed using DTNB and insulin reduction assays 
respectively to determine their specific activities. The activity of BCP was going to be tested 
using a HRP competition assay to determine its second-order rate constant with regard to 
hydrogen peroxide reduction, but due to time constraints, this was not carried out. The in vitro 
characterization of the system will be tested in future studies. 
Overall, novel insights into the M. tuberculosis redox defence network were obtained 
through a combination of systems biology techniques. This work serves as a good starting point 
for further adoption of such approaches in the study of cellular network structures of pathogens 
to clearly understand the interactions between proteins tasked with specific roles within their 
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Computational model script S1: M. tuberculosis unique Bi-Fan motif 
 
#Core model of the Bi-Fan motif in M. tuberculosis 
##################### 
#Reactions with rate expressions# 
##################### 
 
FIX: NADPH NADP H2O2 H2O 
 
# TR, Thioredoxin reductase reaction: 
 
R1: NADPH + TrxBSS = NADP + TrxBSH 
      
kcat1*TR*(NADPH/K1nadph)*(TrxBSS/K1trxbss)/((1+NADPH/K1nadph)*(1+TrxBSS/K1trxbss)) 
   
R2: NADPH + TrxCSS = NADP + TrxCSH 
      
kcat2*TR*(NADPH/K1nadph)*(TrxCSS/K2trxcss)/((1+NADPH/K1nadph)*(1+TrxCSS/K2trxcss)) 
     
# TrxB and TrxC, Thioredoxin Reactions: 
# TrxB reactions with TpxSH/SS and BcpSH/SS below: 
 
R3: TrxBSH + TpxSS = TrxBSS + TpxSH 
       K3*TrxBSH*TpxSS 
     
R4: TrxBSH + BcpSS = TrxBSS + BcpSH 
       K4*TrxBSH*BcpSS 
        
# TrxC reactions with TpxSH/SS and BcpSH/SS below: 
 
R5: TrxCSH + TpxSS = TrxCSS + TpxSH 
       K5*TrxCSH*TpxSS 
        
R6: TrxCSH + BcpSS = TrxCSS + BcpSH 
       K6*TrxCSH*BcpSS 
 
#H2O2 reactions with Prx's TpxSH and BcpSH: 
 
R7: TpxSH + H2O2 = TpxSS + {2} H2O 
       K7*TpxSH*H2O2 
        
R8: BcpSH + H2O2 = BcpSS + {2} H2O 
       K8*BcpSH*H2O2 
             
#Species: 
NADPH = 5 
NADP = 0 
TrxBSH = 0.5 
TrxBSS = 0.5 
TrxCSH = 0.5 
TrxCSS = 0.5 
TR = 5 
TpxSH = 0.5 
TpxSS = 0.5 
BcpSH = 0.5 
BcpSS = 0.5 
H2O2 = 1 
H2O = 0.5 
 
#Rate Parameters: 
kcat1 = 1       
kcat2 = 1 





K1trxbss = 1 
K2trxcss = 1 
K3 = 1 
K4 = 1 
K5 = 1 
K6 = 1 
K7= 1 
K8 = 1 
 
Computational model script S2: Bi-parallel motif for comparison to Bi-Fan motif 
 
#Core model of the Bi-parallel motif to compare to the Mtb Bi-Fan motif 
##################### 
#Reactions with rate expressions# 
##################### 
 
FIX: NADPH NADP H2O2 H2O 
 
# TR, thioredoxin reductase reactions with TrxBSS and TrxCSS: 
 
R1: NADPH + TrxBSS = NADP + TrxBSH 
      
kcat1*TR*(NADPH/K1nadph)*(TrxBSS/K1trxbss)/((1+NADPH/K1nadph)*(1+TrxBSS/K1trxbss)) 
       
R2: NADPH + TrxCSS = NADP + TrxCSH 
      
kcat2*TR*(NADPH/K1nadph)*(TrxCSS/K2trxcss)/((1+NADPH/K1nadph)*(1+TrxCSS/K2trxcss)) 
       
# TrxB side, thioredoxin reaction with Tpx: 
 
R3: TrxBSH + TpxSS = TrxBSS + TpxSH 
      K3*TrxBSH*TpxSS 
       
R4: TpxSH + H2O2 = TpxSS + {2} H2O 
      K4*TpxSH*H2O2 
 
# TrxC side, thioredoxin reaction with Bcp: 
 
R5: TrxCSH + BcpSS = TrxCSS + BcpSH 
      K5*TrxCSH*BcpSS 
 
R6: BcpSH + H2O2 = {2} H2O + BcpSS 
      K6*BcpSH*H2O2 
 
# Species 
NADPH = 5 
NADP = 1 
TrxBSH = 0.5 
TrxBSS = 0.5 
TrxCSH = 0.5 
TrxCSS = 0.5 
TR = 5 
TpxSH = 0.5 
TpxSS = 0.5 
BcpSH = 0.5 
BcpSS = 0.5 
H2O2 = 1 
H2O = 1 
 
#Rate Parameters: 
kcat1 = 1 
kcat2 = 1 





K1trxbss = 1 
K2trxcss = 1 
K3 = 1 
K4 = 1 
K5 = 1 



























Table S1: FANMOD 3 Node Output using 2000 randomizations for E. coli for the motif 


















       






















































Table S2: FANMOD 3 Node Output using 2000 randomizations for S. cerevisiae for the 




























































































Table S3: FANMOD 3 Node Output using 2000 randomizations for M. tuberculosis for the 












z-Score p-Value Motif 
(Sub-graph) 






























































z-Score p-Value Motif 
(Sub-graph) 





































































z-Score p-Value Motif 
(Sub-graph) 























































Table S6: MAVisto 3 Node Output using 2000 randomizations for M. tuberculosis for the 







z-Score p-Value Motif 
(Sub-graph) 





























































































































































































































































































Table S8: FANMOD 4 Node Output using 2000 randomizations for S. cerevisiae for the 





















































































































































































Table S9: FANMOD 4 Node Output using 2000 randomizations for M. tuberculosis for the 







































































































































































z-Score p-Value Motif 
(Sub-graph) 
























































































































































Table S11: MAVisto 4 Node Output using 2000 randomizations for S. cerevisiae for the 







z-Score p-Value Motif 
(Sub-graph) 
























































































































































Table S12: MAVisto 4 Node Output using 2000 randomizations for M. tuberculosis for the 







z-Score p-Value Motif 
(Sub-graph) 



























































































































































=  𝑘𝑐1. 𝐻2𝑂2. 𝑇𝑝𝑥𝑆𝐻 − 𝑣2 − 𝑣5                  (27) 
 
At steady state, 
𝑑𝑇𝑝𝑥𝑆𝑆
𝑑𝑡
 = 0 therefore: 
 
𝑘𝑐1. 𝐻2𝑂2. 𝑇𝑝𝑥𝑆𝐻 − 𝑣2 − 𝑣5 = 0 
where v2 and v5 are equations (25) and (26) (Page 56) above respectively, 
solving for 𝑇𝑝𝑥𝑆𝐻 yields the following equation: 
𝑇𝑝𝑥𝑆𝐻
=
((𝑘2𝑘5𝑇𝑝𝑥𝑆𝑆 + 𝑘2𝑘6𝐵𝑐𝑝𝑆𝑆)(𝑘1𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑁𝐴𝐷𝑃𝐻)(𝑇𝑝𝑥𝑆𝑆) + (𝑘2𝑘5𝑇𝑝𝑥𝑆𝑆 + 𝑘3𝑘5𝐵𝑐𝑝𝑆𝑆)(𝑘4𝑇𝑟𝑥𝐶𝑡𝑜𝑡𝑁𝐴𝐷𝑃𝐻)(𝑇𝑝𝑥𝑆𝑆) + (𝑘1𝑘5(𝑘4𝑇𝑟𝑥𝐶𝑡𝑜𝑡𝑁𝐴𝐷𝑃𝐻)(𝑇𝑝𝑥𝑆𝑆) + 𝑘2𝑘4(𝑘1𝑇𝑟𝑥𝐵𝑡𝑜𝑡𝑁𝐴𝐷𝑃𝐻(𝑇𝑝𝑥𝑆𝑆))𝑁𝐴𝐷𝑃𝐻)
(𝑘1𝑘4𝑘𝑐1𝐻2𝑂2𝑁𝐴𝐷𝑃𝐻
2 + 𝐻2𝑂2𝑁𝐴𝐷𝑃𝐻(𝑘𝑐1(𝑘1𝑘6𝐵𝑐𝑝𝑆𝑆 + 𝑘3𝑘4𝐵𝑐𝑝𝑆𝑆) + 𝑘𝑐1𝑇𝑝𝑥𝑆𝑆(𝑘1𝑘5 + 𝑘2𝑘4)) + 𝑘3𝑘6𝑘𝑐1𝐵𝑐𝑝𝑆𝑆














Figure S1. The Bradford standard curve constructed using a 1 mg/mL bovine serum albumin 
stock solution diluted to concentrations ranging from 0 to 20 µg/mL. Absorbance values were 
measured in triplicate for each concentration (595 nm) and standard error bars are shown. This 
is the linear portion of the original curve (0 to 100 µg/mL) and served to be sufficient for this 
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